DE102008006858A1 - Water-based composition especially useful as a deodorant or antiperspirant comprises an alkoxylated phosphate ester - Google Patents

Abstract

Composition comprising an alkoxylated phosphate ester (I) and more than 50 wt.% water is new. Composition comprising an alkoxylated phosphate ester of formula (I) and more than 50 wt.% water is new. R 1-R 36-30C alkyl, 6-30C alkenyl, or aryl optionally substituted with 1-3 of 3-18C branched alkyl; A 1-A 3CH 2CH 2, C 3H 6 or C 4H 8; x, y, z : 30-150. [Image].

Description

The The invention relates to aqueous compositions containing alkoxylated phosphoric acid triesters and the use this phosphoric acid triester as thickener or associative thickener, especially in cosmetic, pharmaceutical or dermatological Compositions.

At Cosmetic products are made high demands. You should show a clear appearance, toxicologically and ecotoxicologically be safe, create a pleasant feeling on the skin and have an excellent rheological behavior that over a broad pH range is constant.

Water- or solvent-containing multicomponent systems such as emulsions or suspensions are often made from economic Reasons, for application reasons or for reasons of stability to higher viscosities set or thickened.

So can z. B. by increasing the viscosity of the external or internal phase of emulsions or suspensions, that the time to demixing the components of such System can be extended significantly, resulting in a Extension of the storage time makes noticeable. By increase The viscosity is even with many products whose uniform Spreadability improved, especially on uneven surfaces.

By the more even distribution and extended Duration of action is thus increased the effectiveness. In addition to the mentioned application-related advantages offers the high Viscosity of such preparations also has other advantages in the production, packaging, filling and storage as well as during transport.

In The specialized literature will be a variety of different systems indicated to the rheological properties of aqueous or solvent-containing systems, emulsions or suspensions. For example, cellulose ethers and other cellulose derivatives are known (e.g., carboxymethylcellulose, hydroxyethylcellulose), gelatin, Starch and starch derivatives, sodium alginates, fatty acid polyethylene glycol esters, Agar-agar, tragacanth or dextrine. As synthetic polymers come various materials used, such. For example, polyvinyl alcohols, Polyacrylamides, polyacrylic acid and various salts of Polyacrylic acid, polyvinyl pyrrolidone, polyvinyl methyl ether, Polyethylene oxides, copolymers of maleic anhydride and Vinyl methyl ether, as well as various mixtures and copolymers of the above compounds.

The However, compounds mentioned in the application show manifold Disadvantage. So z. As the cellulose derivatives or generally the based on natural resources and materials the resulting formulations very vulnerable against bacteria. From an application point of view, they mostly fall through education unpleasant, "thread-pulling" gels. Fettsäurepolyethylenglykolester tend to hydrolysis in the presence of water, the resulting insoluble fatty acids cause unwanted Opacities. Thickening agents of natural origin (eg agar-agar or tragacanth) have a strongly varying depending on origin Composition on.

Cosmetic preparations containing long-chain mono- and di-phosphoric acid esters are disclosed in DE 10 2004 047 092 . US 6,448,297 and DE 10 2004 046 356 described and the emulsifier effect of the phosphoric acid esters used. A sufficiently thickening effect of the phosphoric acid esters is not observed.

In JP 09268193 a process for the preparation of alkoxylated Phosphorsäuretriestern having 1 to 50, preferably 1 to 10 alkoxy groups, described and pointed out their use in cosmetic products, wherein advantageously uses the skin-friendly properties of the triester, and their low viscosities and low melting points. Evidence of a thickening effect of formulations based on water are not given.

US 5,129,462 describes shampoo formulations comprising polyethylene glycol polyol fatty acid esters, in particular PEG pentaerythritol fatty acid esters as thickeners. The processing and formability of this class of compounds is impaired by their high melting points or pour points.

EP 1 518 900 and EP 1 344 518 disclose cosmetic and pharmaceutical preparations containing oxalkylated polyglycerol esters as thickeners, dispersants for aqueous, aqueous-alcoholic and aqueous-surfactant preparations and as emulsifiers, suspending agents with thickening effect and Konsis for emulsions and suspensions.

The in the mentioned writings US 5,129,462 . EP 1 518 900 and EP 1 344 518 On the one hand, associative thickeners still have room for improvement in terms of their thickening performance, especially in purely aqueous systems, where they form only cloudy gels, but also in terms of their stability at low pH. At pH values below 5, their gels and thickened surfactant solutions are not storage-stable, but lose their viscosity very quickly.

task The invention was therefore a novel class of substances available to be used as thickeners for aqueous compositions, in particular for cosmetic, dermatological or pharmaceutical aqueous compositions suitable for the formulations gives a clear appearance and also in a strong acidic medium or at high electrolyte contents a high thickening capacity caused by temperature load and after long storage times.

It It was surprisingly found that this task was solved is characterized by the alkoxylated phosphoric acid esters described below of the formula (I) which alkoxylated Phosphorsäuretriester represent.

• A) einen oder mehrere Phosphorsäureester gemäß der Formel (I)
  
  worin R₁, R₂ und R₃ gleich oder verschieden sein können und für eine lineare oder verzweigte, gesättigte Alkylgruppe mit 6 bis 30, vorzugsweise 8 bis 22, besonders bevorzugt 12 bis 18 Kohlenstoffatomen, für eine lineare oder verzweigte, ein- oder mehrfach ungesättigte Alkenylgruppe mit 6 bis 30, vorzugsweise 8 bis 22 und besonders bevorzugt 12 bis 18 Kohlenstoffatomen, oder für eine Arylgruppe, insbesondere eine Phenylgruppe, die mit 1 bis 3 verzweigten Alkylgruppen, die jeweils unabhängig voneinander 3 bis 18 und vorzugsweise 4 bis 12 Kohlenstoffatome enthalten, substituiert sein kann, steht, die einzelnen Gruppen (OA₁)_x, (A₂O)_y und (A₃O)_z jeweils unabhängig voneinander aus Einheiten ausgewählt aus CH₂CH₂O, C₃H₆O und C₄H₈O bestehen und wobei die Einheiten CH₂CH₂O, C₃H₆O und C₄H₈O innerhalb der einzelnen Gruppen (OA₁)_x, (A₂O)_y und (A₃O)_z blockartig oder statistisch verteilt angeordnet sein können, und x, y und z jeweils unabhängig voneinander eine Zahl von 30 bis 150, bevorzugt von 40 bis 120 und besonders bevorzugt von 51 bis 100, bedeuten, und
• B) Wasser in einer Menge > 50,0 Gew.-%, bevorzugt in einer Menge > 70,0 Gew.-% und besonders bevorzugt in einer Menge von 75,0 bis 95,0 Gew.-%, bezogen auf die fertige Zusammensetzung.

The present invention therefore relates to compositions containing

• A) one or more phosphoric acid esters of the formula (I)
  
  wherein R ₁ , R ₂ and R _{3 may be the} same or different and is a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22, particularly preferably 12 to 18 carbon atoms, a linear or branched, one or more times unsaturated alkenyl group having 6 to 30, preferably 8 to 22 and particularly preferably 12 to 18 carbon atoms, or an aryl group, in particular a phenyl group containing 1 to 3 branched alkyl groups, each independently 3 to 18 and preferably 4 to 12 carbon atoms , may be substituted, the individual groups (OA ₁ ) _x , (A ₂ O) _y and (A ₃ O) _{z are} each independently selected from units selected from CH ₂ CH ₂ O, C ₃ H ₆ O and C ₄ H ₈ O and wherein the units CH ₂ CH ₂ O, C ₃ H ₆ O and C ₄ H ₈ O within the individual groups (OA ₁ ) _x , (A ₂ O) _y and (A ₃ O) _z block-like or can be arranged statistically distributed, and x, y and z each independently gig each other is a number from 30 to 150, preferably from 40 to 120 and particularly preferably from 51 to 100, mean, and
• B) water in an amount> 50.0 wt .-%, preferably in an amount> 70.0 wt .-% and particularly preferably in an amount of 75.0 to 95.0 wt .-%, based on the finished Composition.

The Phosphoric acid triesters of the formula (I) may preferably be prepared by the reaction of phosphoric acid or Phosphoric acid derivatives with alkoxylated fatty alcohols, wherein the alkoxylated fatty alcohols are characterized that they carry at least 30 alkoxy groups.

In a preferred embodiment of the present invention, the radicals R ₁ , R ₂ and R ₃ in the phosphoric acid esters of the formula (I) may be identical or different and are a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22 and particularly preferably 12 to 18 carbon atoms, or a linear or branched, mono- or polyunsaturated alkenyl group having 6 to 30, preferably 8 to 22 and particularly preferably 12 to 18 carbon atoms.

In a further preferred embodiment of the present invention, the units OA ₁ , OA ₂ and OA ₃ in the phosphoric esters of the formula (I) are CH ₂ CH ₂ O.

In a particularly preferred embodiment of the present invention, the radicals R ₁ - (OA ₁ ) _x , R ₂ - (OA ₂ ) _y and R ₃ - (OA ₃ ) _z in the phosphoric acid esters of the formula (I) are derived from fatty alcohol etho ethoxylates selected from C _16/18 fatty alcohol ethoxylates having 30 to 150 ethylene oxide units, preferably with 40 to 120 ethylene oxide units, more preferably from C _16/18 fatty alcohol ethoxylate with 50 ethylene oxide units (z. B. Genapol ^® T 500) or C _16/18 fatty alcohol ethoxylate with 80 ethylene oxide units (z. B. Genapol ^® T 800).

In a further preferred embodiment of the present invention, the groups (OA ₁ ) _x , (OA ₂ ) _y and (OA ₃ ) _z in the phosphoric acid esters of the formula (I) are each CH ₂ CH ₂ O- and C ₃ H ₆ O. Built-up units, wherein the CH ₂ CH ₂ O and C ₃ H ₆ O units within the individual groups (OA ₁ ) _x , (OA ₂ ) _y and (OA ₃ ) _z may be arranged block-wise or randomly distributed, and contain in each case 30 to 150, preferably 40 to 120 and more preferably 51 to 100 CH ₂ CH ₂ O units and 0 to 20, preferably 1 to 10 and particularly preferably 2 to 5 C ₃ H ₆ O units.

In a further particularly preferred embodiment of the present invention, the radicals R ₁ - (OA ₁ ) _x , R ₂ - (OA ₂ ) _y and R ₃ - (OA ₃ ) _z in the phosphoric acid esters of the formula (I) are derived from fatty alcohol ethoxylate / propoxylate selected from C _16/18 fatty alcohol ethoxylate / propoxylate having 50 ethylene oxide units and 2 propylene oxide units or C _16/18 fatty alcohol ethoxylate / propoxylate having 50 ethylene oxide units and 5 propylene oxide units.

The contained in the compositions of the invention Phosphoric acid esters can also be mixtures of Represent phosphoric acid esters, wherein the proportion of phosphoric acid triesters then preferably more than 80% by weight, based on the phosphoric acid ester mixture, is.

worin
R₁ für eine lineare oder verzweigte, gesättigte Alkylgruppe mit 6 bis 30, vorzugsweise 8 bis 22 und besonders bevorzugt 12 bis 18 Kohlenstoffatomen, für eine lineare oder verzweigte, ein- oder mehrfach ungesättigte Alkenylgruppe mit 6 bis 30, vorzugsweise 8 bis 22 und besonders bevorzugt 12 bis 18 Kohlenstoffatomen, oder für eine Arylgruppe, insbesondere eine Phenylgruppe, die mit 1 bis 3 verzweigten Alkylgruppen, die jeweils unabhängig voneinander 3 bis 18 und vorzugsweise 4 bis 12 Kohlenstoffatome enthalten, substituiert sein kann, steht,
R₄ für H, Li⁺, Na⁺, K⁺, Mg⁺⁺, Ca⁺⁺, Al⁺⁺⁺, NH₄ ⁺ oder quaternäre Ammoniumionen [HNR^aR^bR^c]⁺ steht, worin R^a, R^b und R^c unabhängig voneinander Wasserstoff, eine lineare oder verzweigte Alkylgruppe mit 1 bis 22 Kohlenstoffatomen, eine lineare oder verzweigte, einfach oder mehrfach ungesättigte Alkenylgruppe mit 2 bis 22 Kohlenstoffatomen, eine lineare Mono-Hydroxyalkylgruppe mit 2 bis 10 Kohlenstoffatomen, bevorzugt eine Mono-Hydroxyethyl- oder Mono-Hydroxypropylgruppe, oder eine lineare oder verzweigte Di-Hydroxyalkylgruppe mit 3 bis 10 Kohlenstoffatomen, bedeuten,
R₅ die Bedeutung von R₁ oder R₄ besitzt,
die einzelnen Gruppen (OA₁)_x und (A₂O)_w jeweils unabhängig voneinander aus Einheiten ausgewählt aus CH₂CH₂O, C₃H₆O und C₄H₈O bestehen und wobei die Einheiten CH₂CH₂O, C₃H₆O und C₄H₈O innerhalb der einzelnen Gruppen (OA₁)_x und (A₂O)_w blockartig oder statistisch verteilt angeordnet sein können,
x für eine Zahl von 30 bis 150, bevorzugt von 40 bis 120 und besonders bevorzugt von 51 bis 100, steht, und
w für 0 oder für eine Zahl von 30 bis 150, bevorzugt von 40 bis 120 und besonders bevorzugt von 51 bis 100, steht,
mit der Maßgabe, dass die Menge der Phosphorsäuretriester gemäß Formel (I) größer 80,0 Gew.-%, bevorzugt von 85,0 bis 99,0 Gew.-% und besonders bevorzugt von 88,0 bis 95,0 Gew.-%, bezogen auf das Gesamtgewicht der Phosphorsäureester gemäß Formel (I) und Formel (II), ist, und der Neutralisationsgrad der nicht veresterten Phosphorvalenzen (P-OH) in den Phosphorsäureestern gemäß Formel (II) zwischen 0 und 100% betragen kann.In a further preferred embodiment of the present invention, in addition to the one or more phosphoric acid esters of the formula (I), the novel compositions comprise one or more phosphoric esters of the formula (II)

wherein
R _{1 is} a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22 and particularly preferably 12 to 18 carbon atoms, for a linear or branched, mono- or polyunsaturated alkenyl group having 6 to 30, preferably 8 to 22 and especially preferably 12 to 18 carbon atoms, or represents an aryl group, in particular a phenyl group, which may be substituted by 1 to 3 branched alkyl groups, each of which independently contains 3 to 18 and preferably 4 to 12 carbon atoms,
R _{4 is} H, Li ⁺ , Na ⁺ , K ⁺ , Mg ⁺⁺ , Ca ⁺⁺ , Al ⁺⁺⁺ , NH ₄ ⁺ or quaternary ammonium ions [HNR ^a R ^b R ^c ] ⁺ , where R ^a , R ^b and R ^{c are} independently hydrogen, a linear or branched alkyl group having 1 to 22 carbon atoms, a linear or branched mono- or polyunsaturated alkenyl group having 2 to 22 carbon atoms, a linear mono-hydroxyalkyl group having 2 to 10 carbon atoms, preferably a mono-hydroxyethyl or mono-hydroxypropyl group, or a linear or branched dihydroxyalkyl group having 3 to 10 carbon atoms,
R _{5 has} the meaning of R ₁ or R ₄ ,
the individual groups (OA ₁ ) _x and (A ₂ O) _w each independently of one another consist of units selected from CH ₂ CH ₂ O, C ₃ H ₆ O and C ₄ H ₈ O and wherein the units CH ₂ CH ₂ O, C ₃ H ₆ O and C ₄ H ₈ O within the individual groups (OA ₁ ) _x and (A ₂ O) _w can be arranged block-wise or randomly distributed,
x is a number from 30 to 150, preferably from 40 to 120 and particularly preferably from 51 to 100, and
w is 0 or a number from 30 to 150, preferably from 40 to 120 and particularly preferably from 51 to 100,
with the proviso that the amount of the phosphoric acid triesters of the formula (I) is greater than 80.0% by weight, preferably from 85.0 to 99.0% by weight and more preferably from 88.0 to 95.0% by weight. %, based on the total weight of the phosphoric esters according to formula (I) and formula (II), and the degree of neutralization of the non-esterified Phosphorvalences (P-OH) in the phosphoric acid esters of formula (II) can be between 0 and 100%.

In the phosphoric acid esters of the formula (II), R ^{1 is} preferably a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22 and particularly preferably 12 to 18 carbon atoms, or a linear or branched, mono- or polyunsaturated alkenyl group having 6 to 30, preferably 8 to 22 and particularly preferably 12 to 18 carbon atoms. The same applies to R ⁵ if it has the meaning of R ¹ . In this case, however, R ¹ and R ^{5 may be the} same or different.

In the compounds of formula (II) (OA ₁₎ in the case of w = 0 or consist (OA _{1) x} and (A ₂ O) _w in the case w ≠ 0 is preferably made up of units selected from CH ₂ CH ₂ O and C ₃ H ₆ O and more preferably from CH ₂ CH ₂ O units.

The Preparation of the phosphoric acid esters of the formula (I) or of mixtures of the phosphoric acid esters of the formulas (I) and (II) is preferably carried out by reaction of phosphoric acid or their derivatives with fatty alcohol alkoxylates at temperatures between 150 and 250 ° C, preferably between 180 and 240 ° C. and more preferably between 200 and 230 ° C.

preferred Phosphoric acid derivatives are selected from polyphosphoric acid, Tetraphosphorodecoxide, phosphorus oxychloride and phosphorus pentachloride.

preferred Recktand is orthophosphoric acid.

Preferred fatty alcohol alkoxylate reactants are fatty alcohol ethoxylates, more preferably fatty alcohol ethoxylates having from 30 to 150 EO units (EO = CH ₂ CH ₂ O), more preferably from 40 to 120 EO units, and most preferably from 51 to 100 EO units, said respective fatty alcohol radical (R ₁ O-, R ₂ O- and / or R ₃ O-), is derived from alcohols selected from octanol, decanol, dodecanol, tetradecanol, hexadecanol, octadecanol, eicosanol, behenyl, fatty alcohols with C-chain sections between 8 and 22, preferably C ₁₀ / C ₁₂ fatty alcohol, C ₁₂ / C ₁₄ fatty alcohol, C ₁₂ / C ₁₅ fatty alcohol and C ₁₆ / C ₁₈ fatty alcohol, branched fatty alcohols, preferably Guerbet alcohols and monounsaturated fatty alcohols, preferably delta -9-cis-hexadecanol, delta-9-cis-octadecanol, trans-9-octadecanol and cis-delta-11-octadecanol.

Other preferred fatty alcohol alkoxylate reactants are fatty alcohol ethoxy-propoxylates, more preferably fatty alcohol ethoxy-propoxylates having 30 to 150 CH ₂ CH ₂ O units (EO) and 0 to 20 C ₃ H ₆ O units (PO), more preferably 40 to 120 EO and 2 to 10 PO units and exceptionally preferred having 51 to 100 EO and 2 to 5 PO units, the fatty alcohol radicals being derived from the fatty alcohols mentioned above.

The Esterification is preferably carried out to the extent that in Substantially neutral Phosphorsäuretriester present. A degree of conversion of> 80% is preferred, d. H. more than 80% of all esterifiable functions of phosphoric acid or phosphoric acid derivatives are esterified. Especially preferred is a degree of conversion> 90%, particularly preferably> 95%.

The remaining free valencies on the phosphorus atom may be acid groups, but also counterions selected from Li ⁺ , Na ⁺ , K ⁺ , Mg ⁺⁺ , Ca ⁺⁺ , Al ⁺⁺⁺ , NH ₄ ⁺ , quaternary ammonium ions [HNR ^a R ^b R ^c ] ⁺ , wherein R ^a , R ^b and R ^{c are} independently hydrogen, a linear or branched alkyl group having 1 to 22 carbon atoms, a linear or branched, mono- or polyunsaturated alkenyl group having 2 to 22 carbon atoms, a linear mono-hydroxyalkyl group with May be 2 to 10 carbon atoms, preferably a mono-hydroxyethyl or mono-hydroxypropyl group, as well as a linear or branched di-hydroxyalkyl group having 3 to 10 carbon atoms.

Of the Neutralization degree of unsubstituted phosphorus valencies (P-OH) can be between 0 and 100%.

In a preferred embodiment of the invention are the contained in the compositions of the invention Phosphoric acid esters of the formula (II) neutralized with a degree of neutralization of 0-20.0%.

In another preferred embodiment of the invention are those in the compositions of the invention contained phosphoric acid ester according to the Neutralized formula (II) with a degree of neutralization of 20.1 to 100%.

The compositions according to the invention may contain one or more phosphoric acid esters of Formula (II), wherein R ^{5 has} the meaning of R ⁴ , and w is 0. These compounds are mono-phosphoric acid esters.

In the compositions according to the invention, however, preference is given to those compounds of the formula (II) in which R _{5 has} the meaning of R ₁ and w is a number from 30 to 150, preferably from 40 to 120 and particularly preferably from 51 to 100. These compounds are di-phosphoric acid esters.

The Compositions according to the invention can Mixtures of mono-phosphoric acid ester and di-phosphoric acid ester of the formula (II).

Provided the compositions according to the invention mono-phosphoric acid esters of the formula (II) is the amount thereof, based on the finished Composition, preferably <5.0 Wt .-%, more preferably <3.0 Wt .-%, particularly preferably <1.0 Wt .-% and exceptionally preferably <0.1 wt .-%.

In a further preferred embodiment of the invention contain the compositions of the invention Water in an amount> 90,0 Wt .-%, and preferably in an amount of 90.1 to 95.0 wt .-%, based on the finished composition.

The Phosphoric acid esters of the formula (I) have an excellent Thickening power, both for compositions on watery or aqueous-alcoholic as well for compositions on aqueous-surfactant Base and also tolerate organic solvents like Alcohols.

In the compositions of the invention are the one or more phosphoric acid esters of the formula (I) preferably in amounts of 0.1 to 10.0 wt .-%, more preferably from 0.5 to 8.0 wt%, and more preferably from 1.0 to 6.0 Wt .-%, based on the finished compositions.

The aqueous compositions of the invention have viscosities of 100 to 100,000 mPa · s, preferably from 1000 to 50,000 mPa · s and more preferably from 2000 to 25,000 mPa · s at room temperature.

The Phosphoric acid esters of the formula (I) are more advantageous A way of thickening aqueous-surfactant compositions suitable.

In a further preferred embodiment of the invention contain the compositions of the invention one or more surfactants. Especially in these invention surfactant-containing compositions are the one or more Phosphoric acid esters of the formula (I), preferably in amounts of 0.1 to 5.0 wt .-%, particularly preferably from 0.2 to 4.0 wt .-% and particularly preferably from 0.5 to 3.0 wt .-%, based on the finished surfactant-containing compositions.

The aqueous surfactant according to the invention Compositions have viscosities of 100 to 50,000 mPa · s, preferably from 500 to 25,000 mPa · s and particularly preferably from 1000 to 10,000 mPa · s at room temperature on.

The contained in the compositions of the invention Phosphoric acid esters are characterized by good skin tolerance Made and are for use in cosmetic, dermatological and pharmaceutical compositions.

In a further preferred embodiment of the invention are the compositions of the invention therefore cosmetic, dermatological or pharmaceutical compositions.

The Phosphoric acid esters of the formula (I) have many Possible applications and are suitable for use in aqueous, aqueous-alcoholic and aqueous-surfactant Compositions, emulsions, suspensions, dispersions and sprays.

In a further preferred embodiment of the invention are the compositions of the invention therefore in the form of aqueous, aqueous-alcoholic or aqueous surfactant compositions, in the form of Emulsions, suspensions, dispersions or sprays.

Especially It is also advantageous that the thickening power also is pronounced in strongly acidic medium.

The Phosphoric acid esters of the formula (I) are therefore particularly suitable for thickening and stabilizing acidic cosmetic compositions. This can z. B. cosmetic compositions, the Hydroxy acids, such as lactic acid, glycolic acid, Salicylic acid, citric acid or polyglycolic acids contained in free form or partial neutralization. Farther may contain formulations containing vitamin C or vitamin C derivatives, dihydroxyacetone or skin-whitening actives such as arbutin or Glycyrrhetinsäure and their salts are stabilized.

In a further preferred embodiment of the invention own the compositions according to the invention a pH of from 2 to 10, preferably from 2 to 6, especially preferably from 2.5 to 5, and more preferably from 3 to 4.5.

Especially preferred are compositions according to the invention with a pH of 2.5 to 5, which, based on the total composition, from 0.05 to 3.0% by weight, preferably from 0.05 to 2.0% by weight and more preferably from 0.1 to 1.0% by weight of one or more organic Acids with antimicrobial activity, preferably carboxylic acids with antimicrobial effect, included. Particularly preferred organic Acids with antimicrobial activity are benzoic acid, Sorbic acid, salicylic acid, lactic acid and Anisic acid. These acids can be found in the Compositions according to the invention, preferably in a cosmetic formulation, also in the form of its sodium or potassium salts are used when the pH of the composition is later adjusted to a pH of 2.5 to 5. Here, the free, antimicrobial acid is released. These compositions are particularly preferred because the invention Phosphoric acid ester in contrast to the carboxylic acid esters of the prior art in this pH range, a long-term stable Thickening allow the use of antimicrobial effective acids as a preservative only possible power. This can make other preservatives more likely for skin reactions, eg. Halogenated preservatives, be avoided.

The individual organic acids with antimicrobial activity, preferably the carboxylic acids with antimicrobial activity, are preferably in an amount of 0.05 to 2.0 wt .-% and especially preferably from 0.1 to 1.0 wt .-% in the invention just described Compositions used, based on the total composition.

The Phosphoric acid esters of the formula (I) are also outstandingly suitable as thickeners of electrolyte-containing compositions.

In a further preferred embodiment of the invention contain the compositions of the invention one or more electrolytes.

The electrolyte used are inorganic salts, preferably ammonium or metal salts, particularly preferably halides, for example CaCl ₂ , MgCl ₂ , LiCl, KCl and NaCl, carbonates, hydrogencarbonates, phosphates, sulfates, nitrates, particularly preferably sodium chloride, and / or organic Salts, preferably ammonium or metal salts, particularly preferably glycolic acid, lactic acid, citric acid, tartaric acid, mandelic acid, salicylic acid, ascorbic acid, pyruvic acid, fumaric acid, retinoic acid, sulfonic acids, benzoic acid, kojic acid, fruit acid, malic acid, gluconic acid or galacturonic acid.

When Electrolyte can the inventive Compositions also mixtures of different salts.

The Amount of the one or more electrolytes in the inventive Compositions is preferably from 0.1 to 20.0% by weight, especially preferably from 0.2 to 10.0 wt .-% and particularly preferably from 0.5 to 5.0 wt .-%, based on the finished composition.

Very It is advantageous that the phosphoric acid esters of the formula (I) also compositions containing oxidizing agents, preferably hydrogen peroxide, contain, for example, hair dyes, both thicken as also stabilize.

A Further preferred embodiments of the invention are inventive Compositions which release hydrogen peroxide or hydrogen peroxide Contain substances and preferably in the form of gels or creams.

When Hydrogen peroxide-releasing substances are preferably present in Considering inorganic peracids, preferably peroxosulphuric acid, Peroxodisulfuric acid, peroxocarbonates, and organic peracids, preferably peracetic acid.

In a further preferred embodiment of the invention the compositions according to the invention are acidic Hydrogen peroxide bleaching gels or creams.

Especially in aqueous deodorant or antiperspirant formulations containing aluminum salts, preferably aluminum chlorohydrate or Aluminum-zirconium complex salts reduce the amount contained therein Phosphoric acid esters of the formula (I) after application of the formulations on the skin the formation of white residues on the subsequently dressed clothes.

A Further preferred embodiment of the invention are therefore Compositions according to the invention characterized are characterized in that they deodorant or antiperspirant formulations are, in particular deodorant or antiperspirant formulations containing one or more aluminum salts, preferably aluminum chlorohydrate or aluminum-zirconium complex salts.

One Another object of the invention is further the use of a or more phosphoric acid esters of the formula (I) in deodorant or antiperspirant formulations to reduce formation white residue on clothes after Application of the deodorant or antiperspirant formulation on the Skin.

The Phosphoric acid esters of the formula (I) are also advantageous As thickener, bodying agent, emulsifier, sensory additive, Solubilizer, dispersant, lubricant, adhesive and stabilizer suitable.

One Another object of the invention is therefore the use of a or more phosphoric acid esters of the formula (I) in the compositions according to the invention as thickener, Consistency regulator, emulsifier, sensory additive, solubilizer, dispersant, Lubricant, adhesive and stabilizer.

Especially preferred is the use of one or more phosphoric acid esters of the formula (I) in the compositions according to the invention as a thickener.

The Phosphoric acid esters of the formula (I) can in an advantageous As a thickener for inventive Compositions on aqueous or aqueous-alcoholic Base, for example hair gels, moisturizing gels, antiperspirant gels, Bleaching gels, conditioners and disinfecting gels used become. Furthermore, the phosphoric acid esters are suitable of the formula (I) in an advantageous manner as stabilizer, dispersant and bodying agent for inventive aqueous-surfactant compositions, for example shampoos, Shower baths, shower gels and bubble baths and to Improvement of skin mildness and skin compatibility.

The thickening effect of the phosphoric acid esters of the formula (I) in aqueous surfactant according to the invention Compositions become due to the association of the hydrophobic end groups caused by the surfactant micelles and can by the choice of Ethoxylate end groups of the phosphoric acid esters of the formula (I) and controlled by the choice of surfactants.

The suspending or dispersing and stabilizing action of Phosphoric acid esters of the formula (I) in inventive aqueous-surfactant compositions is characterized by the association the hydrophobic end groups and the in aqueous surfactant Compositions of insoluble liquid components, For example, oils and silicone oils, or the insoluble Solid components, such as pigments and agents such Zinc pyrithione, conditional.

The Phosphoric acid esters of the formula (I) are also suitable as Thickeners and dispersants, as emulsifiers, suspending agents with thickening effect and bodying agent for emulsions and suspensions, such as conditioners, as well as lubricants, adhesives, Thickeners, dispersants and emulsifiers decorative, solids-containing Preparations. In this case, mixtures of phosphoric acid esters of the formula (I) can be used. The emulsifying, stabilizing and / or consistency-giving effect of the phosphoric acid esters of the formula (I) in emulsions is characterized by an association of the hydrophobic End groups with each other, as well as by an interaction of the hydrophobic End groups caused by the hydrophobic oil components or reinforced.

In a preferred embodiment of the invention, the cosmetic, pharmaceutical or dermatological compositions as emulsions.

at The emulsions can be both water-in-oil emulsions as well as oil-in-water emulsions, microemulsions and multiple Emulsions act.

The Preparation of the emulsions can in known manner, d. H. for example by hot, hot / cold or PIT emulsification.

Of the non-aqueous content of the emulsions, which is largely from the emulsifier, the thickener and the oil body is usually from 5.0 to 49.0% by weight and preferably at 15.0 to 45.0 wt%. It follows that the Emulsions 51.0 to 95.0% by weight and preferably 55.0 to 85.0% by weight may contain the aqueous phase, depending of it, whether lotions with a comparatively low, or creams and ointments with high viscosity are to be produced.

In a further preferred embodiment of the invention The phosphoric acid esters of the formula (I) are in rinse-off Products, preferably shampoos, shower rooms, shower gels and Foam baths, used.

In a further preferred embodiment of the invention the phosphoric acid esters of the formula (I) are in leave-on Products, preferably skincare products such as day creams, night creams, Moisturizing lotions and gels, aqueous gels, such as z. B. face toners, care creams, nutritional creams, body lotions, Ointments, sunscreens, lip balms, antiperspirants and deodorants.

Of Furthermore, they are also suitable for inventive surfactant-free, aqueous compositions and emulsions as well as for hair conditioners, hair conditioners and hair gels, but also for permanent wave agents, hair dyes, as well as for decorative cosmetics, such as make-ups, Eye shadows, lipsticks, mascara and the like.

The Compositions according to the invention can anionic, cationic, nonionic, ampholytic surfactants and / or Betaine surfactants included.

The Total amount of in the compositions of the invention (eg in the case of rinse-off products) surfactants used, based on the finished compositions according to the invention, preferably from 1.0 to 48.0% by weight, more preferably from 5.0 to 40.0 wt .-% and particularly preferably from 10.0 to 35.0 wt .-%.

Preferred anionic surfactants are (C ₁₀ -C ₂₂ ) -alkyl and alkylene carboxylates, alkyl ether carboxylates, fatty alcohol sulfates, fatty alcohol ether sulfates, alkyl amide sulfates and sulfonates, fatty acid alkylamide polyglycol ether sulfates, alkanesulfonates and hydroxyalkanesulfonates, olefin sulfonates, acyl esters of isethionates, α-sulfofatty acid esters, alkylbenzenesulfonates, alkylphenol glycol ether sulfonates , Sulfosuccinates, sulfosuccinic monoesters and diesters, fatty alcohol phosphates, fatty alcohol ether phosphates, protein-fatty acid condensation products, alkyl monoglyceride sulfates and sulfonates, alkyl glyceride ether sulfonates, fatty acid methyltaurides, fatty acid sarcosinates, sulforicinoleates, acylglutamates and acylglycinates. These compounds and their mixtures are used in the form of their water-soluble or water-dispersible salts, for example the sodium, potassium, magnesium, ammonium, mono-, di- and triethanolammonium and analogous alkylammonium salts.

The Amount of anionic surfactants in the inventive Compositions are preferably from 2.0 to 30.0% by weight, more preferably from 5.0 to 25.0% by weight and especially preferred from 12.0 to 22.0 wt .-%, based on the finished compositions.

Preferred cationic surfactants are quaternary ammonium salts, such as di- (C ₈ -C ₂₂ ) -alkyldimethylammonium chloride or bromide, preferably di- (C ₈ -C ₂₂ ) -alkyldimethylammonium chloride or bromide; (C ₈ -C ₂₂ ) alkyldimethyl-dimethylammonium chloride or bromide; (C ₈ -C ₂₂ ) alkyltrimethylammonium chloride or bromide, preferably cetyltrimethylammonium chloride or bromide, and (C ₈ -C ₂₂ ) -alkyltrimethylammonium chloride or bromide; (C ₁₀ -C ₂₄ ) alkyldimethylbenzylammonium chloride or bromide, preferably (C ₁₂ -C ₁₈ ) alkyldimethylbenzylammonium chloride, (C ₈ -C ₂₂ ) -alkyldimethylhydroxyethylammonium chloride, phosphate, sulfate, lactate, (C ₈ -C ₂₂ ) -alkylamidopropyltrimethylammonium chloride, methosulfate, N, N-bis (2-C ₈ -C ₂₂ -alkanoyl-oxyethyl) -dimethylammonium chloride, methosulfate, N, N-bis (2-C ₈ - C ₂₂ alkanoyl-oxyethyl) hydroxyethyl-methyl-ammonium chloride, methosulfate.

The Amount of cationic surfactants in the inventive Compositions are preferably from 0.1 to 10.0% by weight, more preferably from 0.5 to 7.0% by weight and especially preferred from 1.0 to 5.0 wt .-%, based on the finished compositions.

Preferred nonionic surfactants are fatty alcohol ethoxylates (alkylpolyethylene glycols); Alkylphenolpolyethylenglykole; Fatty amine ethoxylates (alkylaminopolyethylene glycols); Fatty acid ethoxylates (acyl polyethylene glycols); Polypropylenglykolethoxylate (Pluronics ^®); Fatty acid alkanolamides, (fatty acid amide polyethylene glycols); Saccharoseester; Sorbitol esters and sorbitan esters and their polyglycol ethers, and C ₈ -C ₂₂ -Alkylpolyglucoside.

The Amount of nonionic surfactants in the inventive Compositions (eg in the case of rinse-off products) preferably in the range of 1.0 to 20.0 wt .-%, particularly preferably from 2.0 to 10.0 wt%, and more preferably from 3.0 to 7.0 Wt .-%, based on the finished compositions.

Furthermore, the compositions of the invention may contain amphoteric surfactants. These may be described as derivatives of long chain secondary or tertiary amines having an alkyl group of 8 to 18 carbon atoms and in which another group is substituted with an anionic group that mediates water solubility, such as. B. with a carboxyl, sulfate or sulfonate group. Preferred amphoteric surfactants are N- (C ₁₂ -C ₁₈ ) -alkyl-β-aminopropionates and N- (C ₁₂ -C ₁₈ ) -alkyl-β-iminodipropionates as the alkali metal and mono-, di- and trialkylammonium salts; Suitable further surfactants are also amine oxides. These are oxides of tertiary amines with a long-chain group of 8 to 18 carbon atoms and two mostly short-chain alkyl groups with 1 to 4 carbon atoms. Preference is given here, for example, to the C ₁₀ - to C ₁₈ -alkyldimethylamine oxides, fatty acid-amidoalkyl-dimethylamine oxide.

Another preferred group of surfactants are betaine surfactants, also called zwitterionic surfactants. These contain in the same molecule a cationic group, in particular an ammonium group and an anionic group, which may be a carboxylate group, sulfate group or sulfonate group. Suitable betaines are preferably alkylbetaines such as coco-betaine or fatty acid alkylamidopropylbetaines, for example cocoacylamidopropyldimethylbetaine or the C ₁₂ - to C ₁₈ -dimethylaminohexanoates or the C ₁₀ - to C ₁₈ -acylamidopropanedimethylbetaines.

The Amount of amphoteric surfactants and / or betaine surfactants in the inventive Compositions are preferably from 0.5 to 20.0% by weight and particularly preferably from 1.0 to 10.0 wt .-%, based on the finished compositions.

preferred Surfactants are lauryl sulfate, laureth sulfate, cocoamidopropyl betaine, Alkylbetaines such as coco-betaine, sodium cocoylglutamate and lauroamphoacetate.

In a further preferred embodiment of the invention contain the compositions of the invention additionally as foam enhancing agent Co-surfactants from the group of alkylbetaines, alkylamidobetaines, aminopropionates, Aminoglycinates, imidazolinium betaines and sulfobetaines, amine oxides, fatty acid alkanolamides and polyhydroxyamides.

The Compositions according to the invention can as additional auxiliaries and oil body oils, Silicone oils, waxes, emulsifiers, co-emulsifiers, solubilizers, Stabilizers, cationic polymers, film formers, thickeners, gelling agents, superfatting agents, Anti-fats, antimicrobial agents, biogenic agents, Astringents, deodorants, sunscreens, antioxidants, Humectants, solvents, dyes, fragrances, Pearlescing, opacifying and / or water-soluble Contain silicones.

The oil bodies can advantageously be selected from the groups of triglycerides, natural and synthetic Fat bodies, preferably esters of fatty acids with alcohols of low C number, z. B. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids low C number or with fatty acids or from the group the alkyl benzoates, as well as natural or synthetic Hydrocarbon oils.

Suitable triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated, C ₈ -C ₃₀ -fatty acids, in particular vegetable oils, such as sunflower, maize, soybean, rice, jojoba, babussu, pumpkin, Grapeseed, sesame, walnut, apricot, orange, wheat germ, peach kernel, macadamia, avocado, sweet almond, meadowfoam, castor oil, olive oil, peanut oil, Rapeseed oil and coconut oil, as well as synthetic triglyceride oils, e.g. As the commercial product Myritol ^® 318. Also hardened triglycerides are inventively preferred. It is also possible to use oils of animal origin, for example beef tallow, perhydrosqualene, lanolin.

Another class of preferred oil bodies are the benzoic acid esters of linear or branched C _8-22 alkanols, e.g. , The commercial products Finsolv ^® SB (isostearyl benzoate), Finsolv ^® TN _(C12-C15 alkyl benzoate) and Finsolv EB ^® (ethylhexyl).

Another class of preferred oil bodies are the dialkyl ethers having a total of 12 to 36 carbon atoms, in particular having 12 to 24 carbon atoms, such as. As di-n-octyl ether (Cetiol ^® OE), di-n-nonyl ether, di-n-decyl ether, di-n-undecyl ether, di-n-dodecyl ether, n-hexyl-n-octyl ether, n-octyl n -decyl ether, n-decyl-n-undecyl ether, n-undecyl-n-dodecyl ether and n-hexyl-n-undecyl ether, di-3-ethyldecyl ether, tert-butyl-n-octyl ether, iso-pentyl-n-octyl ether and 2-methyl-pentyl-n-octyl ether and di-tert-butyl ether and di-iso-pentyl ether.

As well Branched saturated or unsaturated can be considered Fatty alcohols having 6 to 30 carbon atoms, e.g. B. isostearyl alcohol, as well as Guerbet alcohols.

Another class of preferred oil bodies are hydroxycarboxylic acid alkyl esters. Preferred hydroxycarboxylic acid alkyl esters are full esters of glycolic acid, lactic acid, malic acid, tartaric acid or citric acid. Further basically suitable esters of hydroxycarboxylic acids are esters of β-hydroxypropionic acid, tartronic acid, D-gluconic acid, sugar acid, mucic acid or glucuronic acid. As the alcohol component of these esters are primary, linear or branched aliphatic alcohols having 8 to 22 carbon atoms. The esters of C ₁₂ -C ₁₅ fatty alcohols are particularly preferred. Esters of this type are commercially available, e.g. B. under the trade name Cosmacol ^® the EniChem, Augusts Industriale.

Another class of preferred oily substances are dicarboxylic acid esters of linear or branched C ₂ -C ₁₀ alkanols, such as di-n-butyl adipate (Cetiol ^® B), di- (2-ethylhexyl) adipate and di- (2-ethylhexyl) - succinate and diol esters such as ethylene glycol dioleate, ethylene glycol di-isotridecanoate, propylene glycol di (2-ethylhexanoate), propylene glycol di-isostearate, propylene glycol di-pelargonate, butanediol di-isostearate and neopentyl glycol dicaprylate, and di-isotridecyl acelate.

Likewise preferred oil bodies are symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, glycerol carbonate or dicaprylyl carbonate (Cetiol ^® CC).

Another class of preferred oil bodies are the esters of dimers of unsaturated C ₁₂ -C ₂₂ fatty acids (dimer fatty acids) with monovalent linear, branched or cyclic C ₂ -C ₁₆ -alkanols or with polyvalent linear or branched C ₂ -C ₆ -alkanols.

Another class of preferred oil bodies are hydrocarbon oils, for example those with linear or branched, saturated or unsaturated C ₇ -C ₄₀ -carbon chains, for example Vaseline, dodecane, isododecane, cholesterol, lanolin, synthetic hydrocarbons such as polyolefins, in particular polyisobutene, hydrogenated polyisobutene, Polydecane, as well as hexadecane, isohexadecane, paraffin oils, isoparaffin oils, e.g. As the commercial products of Permethyl ^® series, squalane, squalene, and alicyclic hydrocarbons, eg. As the commercial product 1,3-di- (2-ethyl-hexyl) -cyclohexane (Cetiol ^® S), ozokerite, and ceresin.

Dimethylpolysiloxanes and cyclomethicones, polydialkylsiloxanes R ₃ SiO (R ₂ SiO) _x SiR ₃ , where R is methyl or ethyl, particularly preferably methyl, and x is a number from 2 to 500, are preferably available for silicone oils or waxes , for example, under the trade name Vicasil (General Electric Company), DOW CORNING 200, DOW CORNING 225, DOW CORNING 200 (Dow Corning Corporation), available dimethicone, and under SilCare® ^® Silicone 41M65, SilCare® ^® Silicone 41M70, SilCare® ^® Silicone 41M80 Dimethicone (Clariant) available, Stearyldimethylpolysiloxan, C ₂₀ -C ₂₄ alkyl dimethyl polysiloxane, C ₂₄ -C ₂₈ alkyl dimethyl polysiloxane, but also the under SilCare ^® Silicone 41M40, SilCare ^® Silicone 41M50 (Clariant) available Methicone, further Trimethylsiloxysilicate [ (CH ₂ ) ₃ SiO) _1/2 ] _x [SiO ₂ ] _y , where x is a number from 1 to 500 and y is a number from 1 to 500, dimethiconols R ₃ SiO [R ₂ SiO] _x SiR ₂ OH and HOR ₂ S iO [R ₂ SiO] _x SiR ₂ OH, where R is methyl or ethyl and x is a number up to 500, polyalkylaryl siloxanes, for example those sold under the trade names SF 1075 METHYLPHENYL FLUID (General Electric Company) and 556 COSMETIC GRADE PHENYL TRIMETHICONE FLUID (Dow Corning Corporation) available polymethylphenylsiloxanes, polydiarylsiloxanes, silicone resins, cyclic silicones and amino, fatty acid, alcohol, polyether, epoxy, fluorine and / or alkyl-modified silicone compounds, and polyethersilo xan copolymers.

The Compositions according to the invention can Waxes, for example paraffin waxes, microwaxes and ozokerites, Beeswax and its sub-fractions and beeswax derivatives, Waxes from the group of homopolymeric polyethylenes or copolymers α-olefins, as well as natural waxes such as rice wax, Candeilila wax, carnauba wax, Japan wax or shellac wax included.

When Emulsifiers, co-emulsifiers and solubilizers can nonionic, anionic, cationic or amphoteric surfactants Connections are used.

Suitable nonionic surface-active compounds are preferably addition products of from 0 to 30 mol of ethylene oxide and / or from 0 to 5 mol of propylene oxide to linear fatty alcohols having from 8 to 22 carbon atoms, to fatty acids having from 12 to 22 carbon atoms, to alkylphenols having from 8 to 15 C atoms in the alkyl group and on sorbitol or sorbitol esters; (C ₁₂ -C ₁₈ ) fatty acid mono- and diesters of addition products of 0 to 30 moles of ethylene oxide with glycerol; Glycerol mono- and diesters and sorbitan mono- and diesters of saturated and unsaturated fatty acids having 6 to 22 carbon atoms and optionally their ethylene oxide addition products; Addition products of 15 to 60 moles of ethylene oxide with castor oil and / or hydrogenated castor oil; Polyol and in particular polyglycerol esters, such as. Polyglycerol polyricinoleate and polyglycerol poly-12-hydroxy stearate. Also preferably suitable are ethoxylated fatty amines, fatty acid amides, fatty acid alkanolamides and mixtures of compounds of several of these classes of substances.

When ionogenic co-emulsifiers are suitable for. B. anionic emulsifiers, such as mono-, di- or tri-phosphoric acid esters, soaps (e.g. As sodium stearate), fatty alcohol sulfates but also cationic emulsifiers such as mono-, di- and tri-alkyl quats and their polymeric derivatives.

At Amphoteric emulsifiers are preferably available Alkylaminoalkylcarboxylic acids, betaines, sulfobetaines and Imidazoline derivatives.

Especially Fatty alcohol ethoxylates are preferably used from the group of ethoxylated stearyl alcohols, isostearyl alcohols, Cetyl alcohols, isocetyl alcohols, oleyl alcohols, lauryl alcohols, isolauryl alcohols, Cetylstearyl alcohols, in particular polyethylene glycol (13) stearyl ether, Polyethylene glycol (14) stearyl ether, polyethylene glycol (15) stearyl ether, Polyethylene glycol (16) stearyl ether, polyethylene glycol (17) stearyl ether, Polyethylene glycol (18) stearyl ether, polyethylene glycol (19) stearyl ether, Polyethylene glycol (20) stearyl ether, polyethylene glycol (12) isostearyl ether, Polyethylene glycol (13) isostearyl ether, polyethylene glycol (14) isostearyl ether, Polyethylene glycol (15) isostearyl ether, polyethylene glycol (16) isostearyl ether, Polyethylene glycol (17) isostearyl ether, polyethylene glycol (18) isostearyl ether, Polyethylene glycol (19) isostearyl ether, polyethylene glycol (20) isostearyl ether, Polyethylene glycol (13) cetyl ether, polyethylene glycol (14) cetyl ether, Polyethylene glycol (15) cetyl ether, polyethylene glycol (16) cetyl ether, Polyethylene glycol (17) cetyl ether, polyethylene glycol (18) cetyl ether, Polyethylene glycol (19) cetyl ether, polyethylene glycol (20) cetyl ether, Polyethylene glycol (13) isocetyl ether, polyethylene glycol (14) isocetyl ether, Polyethylene glycol (15) isocetyl ether, polyethylene glycol (16) isocetyl ether, Polyethylene glycol (17) isocetyl ether, polyethylene glycol (18) isocetyl ether, Polyethylene glycol (19) isocetyl ether, polyethylene glycol (20) isocetyl ether, Polyethylene glycol (12) oleyl ether, polyethylene glycol (13) oleyl ether, polyethylene glycol (14) oleyl ether, Polyethylene glycol (15) oleyl ether, polyethylene glycol (12) lauryl ether, Polyethylene glycol (12) isolauryl ether, polyethylene glycol (13) cetyl stearyl ether, Polyethylene glycol (14) cetyl stearyl ether, polyethylene glycol (15) cetyl stearyl ether, Polyethylene glycol (16) cetyl stearyl ether, polyethylene glycol (17) cetyl stearyl ether, Polyethylene glycol (18) cetyl stearyl ether, polyethylene glycol (19) cetyl stearyl ether.

As well preferred are fatty acid ethoxylates selected from the group of ethoxylated stearates, isostearates and oleates, in particular Polyethylene glycol (20) stearate, polyethylene glycol (21) stearate, polyethylene glycol (22) stearate, Polyethylene glycol (23) stearate, polyethylene glycol (24) stearate, polyethylene glycol (25) stearate, Polyethylene glycol (12) isostearate, polyethylene glycol (13) isostearate, Polyethylene glycol (14) isostearate, polyethylene glycol (15) isostearate, Polyethylene glycol (16) isostearate, polyethylene glycol (17) isostearate, Polyethylene glycol (18) isostearate, polyethylene glycol (19) isostearate, Polyethylene glycol (20) isostearate, polyethylene glycol (21) isostearate, Polyethylene glycol (22) isostearate, polyethylene glycol (23) isostearate, Polyethylene glycol (24) isostearate, polyethylene glycol (25) isostearate, Polyethylene glycol (12) oleate, polyethylene glycol (13) oleate, polyethylene glycol (14) oleate, Polyethylene glycol (15) oleate, polyethylene glycol (16) oleate, polyethylene glycol (17) oleate, Polyethylene glycol (18) oleate, polyethylene glycol (19) oleate, polyethylene glycol (20) oleate.

When ethoxylated alkyl ether carboxylic acid or salts thereof advantageously the sodium laureth-11-carboxylate can be used.

When ethoxylated triglycerides may be advantageous in polyethylene glycol (60) Evening Primrose glycerides are used.

Farther it is advantageous to use the polyethylene glycol glycerin fatty acid esters from the group polyethylene glycol (20) glyceryl laurate, polyethylene glycol (6) glyceryl caprate / caprinate, polyethylene glycol (20) glyceryl oleate, Polyethylene glycol (20) glyceryl isostearate and polyethylene glycol (18) glyceryl oleate / cocoate to choose.

Under The sorbitan esters are especially suitable for polyethylene glycol (20) sorbitan monolaurate, Polyethylene glycol (20) sorbitan monostearate, polyethylene glycol (20) sorbitan monoisostearate, Polyethylene glycol (20) sorbitan monopalmitate, polyethylene glycol (20) sorbitan monooleate.

Especially advantageous coemulsifiers are glyceryl monostearate, glyceryl monooleate, Diglyceryl monostearate, glyceryl isostearate, polyglyceryl-3-oleate, Polyglyceryl-3-diisostearate, polyglyceryl-4-isostearate, polyglyceryl-2-dipolyhydroxystearate, Polyglyceryl-4-dipolyhydroxystearate, PEG-30-dipolyhydroxystearate, Diisostearoylpolyglyceryl-3-diisostearate, glycol distearate and polyglyceryl-3-dipolyhydroxystearate, Sorbitan monoisostearate, sorbitan stearate, sorbitan oleate, sucrose distearate, Lecithin, PEG-7 hydrogenated castor oil, cetyl alcohol, stearyl alcohol, Behenyl alcohol, isobehenyl alcohol and polyethylene glycol (2) stearyl ether (Steareth-2), alkyl methicone copolyols and alkyl dimethicone copolyols, especially cetyl dimethicone copolyol, lauryl methicone copolyol.

The Compositions according to the invention can one or more of the emulsifiers, co-emulsifiers or solubilizers in amounts of from 0.1 to 20.0% by weight, preferably from 1.0 to 15.0% by weight and particularly preferably from 3.0 to 10.0 wt .-%, based on the finished compositions.

When Stabilizers can be metal salts of fatty acids, such as For example, magnesium, aluminum and / or zinc stearate used are, preferably in amounts of 0.1 to 10.0 wt .-%, preferably from 0.5 to 8.0% by weight, and more preferably from 1.0 to 5.0% by weight, based on the finished compositions.

When cationic polymers are those under the INCI name "Polyquaternium" known, in particular Polyquaternium-31, Polyquaternium-16, Polyquaternium-24, Polyquaternium-7, Polyquaternium-22, Polyquaternium-39, Polyquaternium-28, Polyquaternium-2, Polyquaternium-10, Polyquaternium-11, as well as Polyquaternium-37 & mineral oil & PPG trideceth (Salcare SC95), PVP-dimethylaminoethyl methacrylate copolymer, guar hydroxypropyl triammonium chlorides, as well as calcium alginate and ammonium alginate. Furthermore you can cationic cellulose derivatives are used; cationic starch; Copolymers of diallyl ammonium salts and acrylamides; quaternierte Vinylpyrrolidone / vinylimidazole polymers; Condensation products of Polyglycols and amines; quaternized collagen polypeptides; quaternierte wheat polypeptides; polyethyleneimines; cationic silicone polymers, such as B. amidomethicones; Copolymers of adipic acid and Dimethylaminohydroxy-propyldiethylentriamin; Polyaminopolyamide and cationic chitin derivatives such as chitosan.

The Compositions according to the invention can one or more of the above-mentioned cationic polymers in quantities from 0.1 to 5.0% by weight, preferably from 0.2 to 3.0% by weight and particularly preferably from 0.5 to 2.0 wt .-%, based on the finished Compositions included.

Furthermore, the compositions of the invention may contain film formers which are selected depending on the application of salts of phenylbenzimidazole sulfonic acid, water-soluble polyurethanes, for example cup Polycarbamylpolyglycerylester, polyvinyl alcohol, Polyvinylpyrrolidoncopolymeren, for example vinylpyrrolidone / vinyl acetate copolymer, water-soluble acrylic acid polymers / copolymers or their esters or salts, water-soluble cellulose such as hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, water-soluble Quaterniums, polyquaterniums, carboxyvinyl polymers, such as carbomers and salts thereof, polysaccharides, for example polydextrose and glucan, vinyl acetate / crotonate, 60 (Clariant), for example, under the trade name Aristoflex ^® A available.

The Compositions according to the invention can one or more film formers in amounts of from 0.1 to 10.0% by weight, preferably from 0.2 to 5.0% by weight, and more preferably from From 0.5 to 3.0% by weight, based on the finished compositions, contain.

The desired viscosity of the compositions can be adjusted by adding further thickeners and gelling agents. Cellulose ethers and other cellulose are preferred derivatives (eg carboxymethylcellulose, hydroxyethylcellulose), gelatin, starch and starch derivatives, sodium alginates, fatty acid polyethylene glycol esters, agar-agar, tragacanth or dextrin derivatives, in particular dextrin esters. Also suitable are metal salts of fatty acids, preferably having 12 to 22 carbon atoms, for example sodium stearate, sodium palmitate, sodium laurate, sodium arachidates, sodium behenate, potassium stearate, potassium palmitate, sodium myristate, aluminum monostearate, hydroxyfatty acids, for example 12-hydroxystearic acid, 16-hydroxyhexadecanoic acid; fatty acid amides; fatty acid; Dibenzal sorbitol and alcohol-soluble polyamides and polyacrylamides or mixtures thereof. Furthermore, crosslinked and uncrosslinked polyacrylates such as carbomer, sodium polyacrylates or sulfonic acid-containing polymers such as Ammoniumacryloyldimethyltaurate / VP copolymer can be used.

Prefers contain the compositions of the invention 0.01 to 20.0 wt .-%, particularly preferably 0.1 to 10.0 wt .-%, in particular preferably 0.2 to 3.0% by weight and most preferably 0.4 to 2.0 wt .-% of thickeners or gelling agents.

As superfatting agent may preferably be lanolin and lecithin, not ethoxylated and polyethoxylated or acylated lanolin and lecithin derivatives, Polyol fatty acid esters, mono-, di- and triglycerides and / or fatty acid alkanolamides, the latter simultaneously serving as foam stabilizers, which are preferably used in amounts of from 0.01 to 10.0% by weight, more preferably from 0.1 to 5.0% by weight and especially preferred from 0.5 to 3.0 wt .-%, based on the finished Compositions of the invention.

Antimicrobial agents include cetyltrimethylammonium chloride, cetylpyridinium chloride, benzethonium chloride, diisobutylethoxyethyldimethylbenzylammonium chloride, sodium N-laurylsarcosinate, sodium N-palmethyl sarcosinate, lauroylsarcosine, N-myristoylglycine, potassium N-laurylsarcosine, trimethylammonium chloride, sodium aluminum chlorohydroxylactate, triethyl citrate, tricetylmethylammonium chloride, 2,4,4'- Trichloro-2'-hydroxydiphenyl ether (triclosan), phenoxyethanol, 1,5-pentanediol, 1,6-hexanediol, 3,4,4'-trichlorocarbanilide (triclocarban), diaminoalkylamide, for example L-lysine hexadecylamide, citrate heavy metal salts, salicylates, piroctose, in particular Zinc salts, pyrithiones and their heavy metal salts, in particular zinc pyrithione, zinc phenol sulfate, farnesol, ketoconazole, oxiconazole, bifonazoles, butoconazoles, cloconazoles, clotrimazoles, econazoles, enilconazoles, fenticonazoles, isoconazoles, miconazoles, sulconazoles, ticonoconazole fluconazoles, itraconazoles, terconazoles, naftifines and terbinafines, p elendisulfid and octopirox ^®, iodopropynyl butylcarbamate, methylchloroisothiazolinone, methylisothiazolinone, Methyldibromo glutaronitrile, AgCl, Chloroxylenol, Na salt of diethylhexyl, sodium benzoate, and phenoxyethanol, benzyl alcohol, phenoxyisopropanol, parabens, preferably butyl, ethyl, methyl and propyl paraben as well as their Na Salts, pentanediol, 1,2-octanediol, 2-bromo-2-nitropropane-1,3-diol, ethylhexylglycerol, benzyl alcohol, sorbic acid, benzoic acid, lactic acid, imidazolidinyl urea, diazolidinyl urea, dimethyloldimethylhydantoin (DMDMH), sodium salt of hydroxymethylglycinate, hydroxyethylglycine sorbic acid and combinations of these active substances are used.

The Contain compositions of the invention the antimicrobial agents are preferred in amounts of 0.001 to 5.0 wt .-%, particularly preferably from 0.01 to 3.0 wt .-% and in particular preferably from 0.1 to 2.0 wt .-%, based on the finished compositions.

The compositions of the invention may further biogenic agents selected from plant extracts such as aloe vera, as well as local anesthetics, antibiotics, anti-inflammatories, anti-allergic agents, corticosteroids, sebostatics, bisabolol ^®, allantoin, phytantriol ^®, proteins, vitamins selected from niacin, biotin, vitamin B2 , Vitamin B3, Vitamin B6, Vitamin B3 derivatives (salts, acids, esters, amides, alcohols), Vitamin C and Vitamin C derivatives (salts, acids, esters, amides, alcohols), preferably as the sodium salt of the monophosphoric acid ester of ascorbic acid or as the magnesium salt of the phosphoric acid ester of ascorbic acid, tocopherol and tocopherol acetate, as well as vitamin E and / or its derivatives.

The Compositions according to the invention can biogenic agents preferably in amounts of 0.001 to 5.0 wt .-%, particularly preferably from 0.01 to 3.0% by weight, and especially preferred from 0.1 to 2.0% by weight, based on the finished compositions, contain.

The compositions according to the invention may contain astringents, preferably magnesium oxide, aluminum oxide, titanium dioxide, zirconium dioxide and zinc oxide, oxide hydrates, preferably alumina hydrate (boehmite) and hydroxides, preferably of calcium, magnesium, aluminum, titanium, zirconium or zinc, and aluminum chlorohydrates, preferably in amounts of from 0 to 50 , 0 wt .-%, more preferably in amounts of from 0.01 to 10.0 Wt .-% and particularly preferably in amounts of 0.1 to 10.0 wt .-%. Preferred deodorants are allantoin and bisabolol. These are preferably used in amounts of 0.0001 to 10.0 wt .-%.

The Compositions according to the invention can as pigments / micropigments and as sunscreen microfine Titanium dioxide, mica titanium oxide, iron oxides, mica iron oxide, zinc oxide, Silicon oxides, ultramarine blue, chromium oxides.

The Compositions according to the invention can Sunscreen filter included, preferably selected from 4-aminobenzoic acid, 3- (4'-trimethylammonium) -benzylidene-borane-2-one-methylsulfate, Camphor benzalkonium methosulfate, 3,3,5-trimethylcyclohexylsalicylate, 2-hydroxy-4-methoxybenzophenone, 2-phenylbenzimidazole-5-sulfonic acid and their potassium, sodium and triethanolamine salts, 3,3- (1,4-phenylenedimethine) bis- (7,7-dimethyl-2-oxobicyclo [2.2.1] heptane-1-methanesulfonic acid) and their salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) propane-1,3-dione, 3- (4'-sulfo) -benzyliden-bornan-2-one and its salts, 2-cyano-3,3-diphenyl-acrylic acid (2-ethylhexyl ester), Polymers of N- [2 (and 4) - (2-oxoborn-3-ylidenemethyl) benzyl] acrylamide, 4-Methoxycinnamic acid 2-ethylhexyl ester, ethoxylated ethyl 4-amino-benzoate, 4-methoxycinnamic acid isoamyl ester, 2,4,6-tris [p- (2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine, 2- (2H-Benzotriazol-2-yl) -4-methyl-6- (2-methyl-3- (1,3,3,3-tetramethyl-1- (trimethylsilyloxy) -disiloxanyl) -propyl) -phenol, 4 4 '- [(6- [4 - ((1,1-dimethylethyl) -amino-carbonyl) phenylamino] -1,3,5-triazine-2,4-yl) diimino] bis (benzoic acid 2- ethylhexyl ester), Benzophenone-3, benzophenone-4 (acid), 3- (4'-methylbenzylidene) -D, L-camphor, 3-Benzylidene-camphor, 2-ethylhexyl salicylate, 2-ethylhexyl 4-dimethylaminobenzoate, Hydroxy-4-methoxybenzophenone-5-sulfonic acid (sulfisobenzone) and the sodium salt, 4-isopropylbenzyl salicylate, N, N, N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) anilium methyl sulphate, homosalates (INN), oxybenzone (INN), 2-phenylbenzimidazole-5-sulphonic acid and their sodium, potassium, and triethanolamine salts, octylmethoxycinnamic acid, Isopentyl-4-methoxycinnamic acid, isoamyl-p-methoxycinnamic acid, 2,4,6-Trianilino- (p-carbo-2'-ethylhexyl-1'-oxy) -1,3,5-triazines (Octyl triazone) Phenol, 2-2 (2H-benzotriazol-2-yl) -4-methyl-6- (2-methyl-3- (1,3,3,3-tetramethyl-1- (trimethylsilyl) oxy) -disiloxanyl ) propyl (Drometrizole trisiloxane) benzoic acid, 4,4 - ((6 - ((((1,1-dimethylethyl) amino) carbonyl) phenyl) amino) -1,3,5-triazine-2,4-diyl) diimino) bis, benzoic acid bis (2-ethylhexyl) ester), 4,4 - ((6 - (((1,1-dimethylethyl) amino) carbonyl) phenyl) amino) -1,3,5-triazine-2,4-diyl) diimino) bis, bis (2-ethylhexyl) ester), 3- (4'-methylbenzylidene) -D, L-camphor (4-methylbenzylidene Camphor), benzylidene-camphorsulfonic acid, octocrylene, polyacrylamidomethyl-benzylidene-camphor, 2-Ethylhexyl salicylate (octyl salicylate), 4-dimethyl-aminobenzoic acid, ethyl 2-hexyl ester (octyl dimethyl PABA), PEG-25 PABA, 2-hydroxy-4-methoxybenzo-phenone-5-sulfonic acid (Benzophenone-5) and the Na salt, 2,2'-methylene-bis-6- (2H-benzotriazol-2yl) -4- (tetramethyl-butyl) -1,1,3,3-phenol, Sodium salt of 2-2'-bis (1,4-phenylene) 1H-benzimidazole-4,6-disulfonic acid, (1,3,5) triazines-2,4-bis ((4- (2-ethyl-hexyloxy) -2-hydroxy) -phenyl) -6- (4-methoxyphenyl), 2-ethylhexyl-2-cyano-3,3-diphenyl-2-propenoate, glyceryl octanoate, Di-p-methoxycinnamic acid, p-aminobenzoic acid and their esters, 4-tert-butyl-4'-methoxydibenzoylmethane, 4- (2-β-glucopyranoxy) propoxy-2-hydroxybenzophenone, Octyl salicylate, methyl 2,5-diisopropyl cinnamic acid, cinoxate, Dihydroxy-dimethoxybenzophenone, disodium salt of 2,2'-dihydroxy-4,4'-dimethoxy-5,5'-disulfobenzophenone, Dihydroxybenzophenone, 1,3,4-dimethoxyphenyl-4,4-dimethyl-1,3-pentanedione, 2-ethylhexyl-dimethoxybenzylidene-dioxoimidazolidine propionate, methylene-bis-benztriazolyl Tetramethylbutylphenol, phenyldibenzimidazole tetrasulfonate, bis-ethylhexyloxyphenol methoxyphenol triazine, Tetrahydroxybenzophenones, Terephthalylidenedicampheresulfonic acid, 2,4,6-tris [4,2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine, methyl bis (trimethylsiloxy) silyl-isopentyl trimethoxycinnamic acid, amyl p-dimethylaminobenzoate, amyl p-dimethylamino benzoate, 2-ethylhexyl-p-dimethylaminobenzoate, isopropyl-p-methoxycinnamic acid / diisopropyl cinnamic acid ester, 2-ethylhexyl-p-methoxycinnamic acid, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and the trihydrate, and 2-hydroxy-4-methoxybenzophenone-5-sulfonate sodium salt and Phenyl-benzimidazole-sulphonic acid.

The Amount of the aforementioned sunscreen filters (one or more compounds) in the compositions of the invention preferably 0.001 to 30.0 wt .-%, particularly preferably 0.05 to 20.0 Wt .-% and in particular 1.0 to 10.0 wt .-%, based on the total weight the finished composition.

The compositions according to the invention may contain antioxidants, preferably selected from amino acids (eg glycine, histidine, tyrosine, tryptophan) and derivatives thereof, imidazoles (eg urocanic acid) and derivatives thereof, peptides such as DL-carnosine, D-carnosine, L-carnosine and its derivatives (eg anserine), carotenoids, carotenes (eg α-carotene, β-carotene, lycopene) and derivatives thereof, chlorogenic acid and its derivatives, lipoic acid and derivatives thereof (eg. Dihydrolipoic acid), aurothioglucose, propylthiouracil and other thiols (eg thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and the like Derivatives (eg, esters, ethers, peptides, lipids, nucleotides, nucleosides and salts), as well as sulfoximine compounds (eg buthionine sulfoximines, homocysteinesulfoximine, buthionine sulfones, penta, hexa, heptathionine sulfoximine) in very low tolerated dosages, furthermore Metal) chelators (eg, α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (eg, citric acid, lactic acid, malic acid), humic acid, bile acids, bile extracts, bilirubin, biliverdin, EDTA, EGTA, and the like Derivatives, unsaturated fatty acids and their derivatives (for example γ-linolenic acid, linoleic acid, oleic acid), folic acid and derivatives thereof, ubiquinone and ubiquinol and derivatives thereof, vitamin C and derivatives (for example ascorbyl palmitate, Mg-ascorbylph osphate, ascorbyl acetate), tocopherols and derivatives (e.g. B. Vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and Koniferylbenzoat the benzoin, rutinic acid and derivatives thereof, α-glycosylrutin, ferulic acid, furfurylidenglucitol, carnosine, butylhydroxytoluene, butylated hydroxyanisole, Nordihydroguajakharzsäure, Nordihydroguajaretsäure, trihydroxybutyrophenone, uric acid and their derivatives, mannose and their derivatives, zinc and its derivatives (eg ZnO, ZnSO ₄ ), selenium and its derivatives (eg selenomethionine), stilbenes and their derivatives (eg stilbene oxide, trans-stilbene oxide) , Superoxide dismutase and the inventively suitable derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these substances.

The Antioxidants can protect the skin and hair from oxidative Protect stress. Preferred antioxidants are while vitamin E and its derivatives as well as vitamin A and its derivatives.

The Amount of the one or more antioxidants in the invention Compositions are preferably from 0.001 to 30.0% by weight, more preferably 0.05 to 20.0% by weight, and particularly preferably 1.0 to 10.0 wt .-%, based on the total weight of the composition.

Of Further, humectants may be selected from the sodium salt of 2-pyrrolidone-5-carboxylate (NaPCA), guanidine; Glycolic acid and its salts, lactic acid and their Salts, glucosamines and their salts, lactamide monoethanolamine, acetamido monoethanolamine, Urea, hydroxy acids, panthenol and its derivatives, for example, D-panthenol (R-2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethylbutamide), DL-panthenol, calcium pantothenate, panthetin, pantotheine, panthenyl ethyl ether, Isopropyl palmitate, glycerol and / or sorbitol are used, preferably in amounts of 0.1 to 15.0 wt .-% and particularly preferably from 0.5 to 5.0 wt .-%, based on the finished compositions.

additionally can the compositions of the invention contain organic solvents. In principle, come as organic solvents all mono- or polyvalent ones Alcohols into consideration. Preference is given to alcohols having 1 to 4 carbon atoms such as ethanol, propanol, isopropanol, n-butanol, i-butanol, t-butanol, Glycerol and mixtures of the mentioned alcohols used. Further preferred alcohols are polyethylene glycols having a relative Molecular mass below 2000. In particular, is an application of Polyethylene glycol with a molecular weight between 200 and 600 and in amounts up to 45.0 wt .-% and of polyethylene glycol with a molecular weight between 400 and 600 in Amounts of 5.0 to 25.0 wt .-% preferred. Other suitable solvents are, for example, triacetin (glycerol triacetate) and 1-methoxy-2-propanol.

The dyes and pigments contained in the compositions according to the invention, both organic and inorganic dyes, are selected from the corresponding positive list of the Cosmetics Ordinance or the EC List of cosmetic colorants. Chemical or other name CIN colour Pigment Green 10006 green Acid Green 1 10020 green 2,4-Dinitrohydroxynaphtalin-7-sulfonic acid 10316 yellow Pigment Yellow 1 11680 yellow Pigment Yellow 3 11710 yellow Pigment Orange 1 11725 orange 2,4-dihydroxyazobenzene 11920 orange Solvent Red 3 12010 red 1- (2'-chloro-4'-nitro-1'-phenylazo) -2-hydroxynaphthalene 12085 red Pigment Red 3 12120 red Ceresrot; Sudan Red; Fat Red G 12150 red Pigment Red 112 12370 red Pigment Red 7 12420 red Pigment Brown 1 12480 brown 4- (2'-methoxy-5'-sulfosäurediethylamid-1'-phenylazo) -3-hydroxy-5 '' - chloro-2 '', 4 '' - dimethoxy-2-naphthoic acid anilide 12490 red Disperse Yellow 16 12700 yellow 1- (4-Sulfo-1-phenylazo) -4-amino-brezol-sulfonic acid 13015 yellow 2,4-dihydroxy-azobenzene-4'-sulfonic acid 14270 orange 2- (2,4-Dimethylphenylazo-5-sulfosäurse) -1-hydroxynaphthalene-4-sulfonic acid 14700 red 2- (4-sulfo-1-naphthylazo) -1-naphthol-4-sulfonic acid 14720 red 2- (6-sulfo-2,4-xylylazo) -1-naphthol-5-sulfonic acid 14815 red 1- (4'-sulfophenylazo) -2-hydroxynaphthalene 15510 orange 1- (2-sulfonic acid 4-chloro-5-carboxylic acid-l-phenylazo) -2-hydroxynaphthalene 15525 red 1- (3-methyl-phenylazo-4-sulfonic acid) -2-hydroxynaphthalene 15580 red 1- (4 ', (8') - Sulfosäurenaphthylazo) -2-hydroxynaphthalene 15620 red 2-hydroxy-1,2'-azonaphthalene-1'-sulfonic acid 15630 red 3-hydroxy-4-phenylazo-2-naphthylcarboxylic acid 15800 red 1- (2-sulfo-4-methyl-1-phenylazo) -2-naphthylcarboxylic acid 15850 red 1- (2-sulfo-4-methyl-5-chloro-1-phenylazo) -2-hydroxynaphthalene-3-carboxylic acid 15865 red 1- (2-sulfo-1-naphthylazo) -2-hydroxynaphthalene-3-carboxylic acid 15880 red 1- (3-sulfo-1-phenylazo) -2-naphthol-6-sulfonic acid 15980 orange 1- (4-Sulfo-1-phenylazo) -2-naphthol-6-sulfonic acid 15985 yellow Allura Red 16035 red 1- (4-sulfo-1-naphthylazo) -2-naphthol-3,6-disulfonic acid 16185 red Acid Orange 10 16230 orange 1- (4-sulfo-1-naphthylazo) -2-naphthol-6,8-disulfonic acid 16255 red 1- (4-sulfo-1-naphthylazo) -2-naphthol-3,6,8 -trisulfosäure, 16290 red 8-amino-2-phenylazo-1-naphthol-3,6-disulfonic acid 17200 red Acid Red 1 18050 red Acid Red 155 18130 red Acid Yellow 121 18690 yellow Acid Red 180 18736 red Acid Yellow 11 18820 yellow Acid Yellow 17 18965 yellow 4- (4-Sulfo-1-phenylazo) -1- (4-sulfophenyl) -5-hydroxyphrazolon-3-carboxylic acid 19140 yellow Pigment Yellow 16 20040 yellow 2,6- (4'-sulfo-2 '', 4 '' - dimethyl) -bisphenylazo) of 1,3-dihydroxybenzene 20170 orange Acid Black 1 20470 black Pigment Yellow 13 21100 yellow Pigment Yellow 83 21108 yellow Solvent Yellow 21230 yellow Acid Red 163 24790 red Acid Red 73 27290 red 2- [4 '- (4''Sulfo-1''- phenylazo) -7'-sulfo-1'-naphthylazo] -1-hydroxy-7-3,6-disulfonic acid aminoaphthalin- 27755 black 4 '- [(4 "-sulfo-1" -phenylazo) -7'-sulfo-1'-naphthylazo] -1-hydroxy-8-acetyl-aminonaphthalene-3,5-disulfonic acid 28440 black Direct Orange 34, 39, 44, 46, 60 40215 orange Food Yellow 40800 orange trans-β-apo-8'-carotenaldehyde (C ₃₀ ) 40820 orange trans-apo-8'-carotenoic acid (C ₃₀ ) ethyl ester 40825 orange canthaxanthin 40850 orange Acid Blue 1 42045 blue 2,4-disulfo-5-hydroxy-4'-4 '' - bis (diethylamino) triphenylcarbinol 42051 blue 4 - [(- 4-N-ethyl-p-sulfobenzylamino) -phenyl- (4-hydroxy-2-sulfophenyl) - (methylene) -1- (N-ethyl-N, N-sulfobenzyl) -2,5-cyclohexadienimine] 42053 green Acid blue 7 42080 blue (N-ethyl-p-sulfobenzylamino-phenyl- (2-sulfophenyl) methylene- (N-ethyl-N, p-sulfo-benzyl) -cyclohexadienimine 42090 blue Acid Green 9 42100 green Diethyl-di-sulfobenzyl-di-4-amino-2-chloro-di-2-methylfuchssonimonium 42170 green Basic Violet 14 42510 violet Basic Violet 2 42520 violet 2'-methyl-4 '- (N-ethyl-Nm-sulfobenzyl) amino-4''- (N-diethyl) amino-2-methyl-N-ethyl-Nm-sulfobenzyl-fuchsonimmonium 42735 blue 4 '- (N-Dimethyl) amino-4''- (N-phenyl) -aminonaphtho-N-dimethyl-fuchsonimmonium 44045 blue 2-hydroxy-3,6-disulfo-4,4'-bisdimethylaminonaphtofuchsinimmonium 44090 green Acid red 45100 red 3- (2'-methylphenylamino) -6- (2'-methyl-4'-sulfophenylamino) -9- (2'-carboxyphenyl) -xantheniumsalz 45190 violet Acid Red 50 45220 red Phenyl-2-oxyfluoron-2-carboxylic acid 45350 yellow 4.5-Dibromofluorescein 45370 orange 2,4,5,7-Tetrabromfluorescein 45380 red Solvent dye 45396 orange Acid Red 98 45405 red 3 ', 4', 5 ', 6'-tetrachloro-2,4,5,7-tetrabromfluorescein 45410 red 4.5-Diiodfluorescein 45425 red 2,4,5,7-tetraiodofluorescein 45430 red quinophthalone 47000 yellow Quinophthalone disulphonic 47005 yellow Acid Violet 50 50325 violet Acid Black 2 50420 black Pigment Violet 23 51319 violet 1,2-dioxyanthraquinone, calcium-aluminum complex 58000 red 3-Oxypyren-5,8,10-sulfonic acid 59040 green 1-hydroxy-4-N-phenyl-aminoanthraquinone 60724 violet 1-hydroxy-4- (4'-methylphenylamino) anthraquinone 60725 violet Acid Violet 23 60730 violet 1,4-di (4'-methylphenylamino) anthraquinone 61565 green 1,4-bis (o-sulfo-p-toluidine) anthraquinone 61570 green Acid Blue 80 61585 blue Acid Blue 62 62045 blue N, N'-dihydro-1,2,1 ', 2'-anthrachinonazin 69800 blue Vat Blue 6; Pigment Blue 64 69825 blue Vat Orange 7 71105 orange indigo 73000 blue Indigo-disulfonic 73015 blue 4,4'-dimethyl-6,6'-dichlorothioindigo 73360 red 5,5'-dichloro-7,7'-dimethylthioindigo 73385 violet Quinacridone Violet 19 73900 violet Pigment Red 122 73915 red Pigment Blue 16 74100 blue phthalocyanines 74160 blue Direct Blue 86 74180 blue chlorinated phthalocyanines 74260 green Natural Yellow 6.19; Natural Red 1 75100 yellow Bixin, nor-bixin 75120 orange lycopene 75125 yellow trans-alpha, beta or gamma-carotene 75130 orange Keto and / or hydroxyl derivatives of carotene 75135 yellow Guanine or pearlescing agent 75170 White 1,7-bis (4-hydroxy-3-methoxyphenyl) 1,6-heptadiene-3,5-dione 75300 yellow Complex salt (Na, Al, Ca) of karmic acid 75470 red Chlorophyll a and b; Copper compounds of chlorophylls and chlorophyllins 75810 green aluminum 77000 White alumina hydrate 77002 White hydrous aluminum silicates 77004 White ultramarine 77007 blue Pigment Red 101 and 102 77015 red barium sulfate 77120 White Bismuth oxychloride and its mixtures with mica 77163 White calcium carbonate 77220 White calcium sulphate 77231 White carbon 77266 black Pigment Black 9 77267 black Carbo medicinalis vegetabilis 77268: 1 black chromium 77288 green Chromium oxide, hydrous 77289 green Pigment Blue 28, Pigment Green 14 77346 green Pigment Metal 2 77400 brown gold 77480 brown Iron oxides and hydroxides 77489 orange Iron oxides and hydroxides 77491 red iron oxide 77492 yellow iron oxide 77499 black Mixtures of iron (II) and iron (III) hexacyanoferrate 77510 blue Pigment White 18 77713 White Mangananimoniumdiphosphat 77742 violet Manganese phosphate; Mn ₃ (PO ₄ ) ₂ * 7H ₂ O 77745 red silver 77820 White Titanium dioxide and its mixtures with mica 77891 White zinc oxide 77947 White 6,7-dimethyl-9- (1'-D-ribityl) -isoalloxazine, lactoflavin yellow caramel brown Capsanthin, Capsorubin orange betanin red Benzopyrilium salts, anthocyanins red Aluminum, zinc, magnesium, and calcium stearate White Bromthymolblau blue bromocresol green Acid Red 195 red

Further advantageous are oil-soluble natural dyes, such as z. As paprika extracts, β-carotene and cochineal.

Pearlescent pigments, eg. As fish silver (guanine / hypoxanthine mixed crystals from fish scales) and mother of pearl (ground mussel shells), monocrystalline pearlescent pigments such. B. Bismuthoxychlorid (BiOCl), layer substrate pigments, z. Example, mica / metal oxide, silver-white pearlescent pigments of TiO ₂ , interference pigments (TiO ₂ , different layer thickness), color luster pigments (Fe ₂ O ₃ ) and combination pigments (TiO ₂ / Fe ₂ O ₃ , TiO ₂ / Cr ₂ O ₃ , TiO ₂ / Berlin Blue, TiO ₂ / Carmine).

In the context of the present invention, effect pigments are to be understood as meaning pigments which, by virtue of their refractive properties, cause particular optical effects. Effect pigments lend the treated surface (skin, hair, mucous membrane) gloss or glitter effects or can optically hide skin irregularities and skin wrinkles through diffuse light scattering. As a particular embodiment of the effect pigments, interference pigments are preferred. Particularly suitable effect pigments are, for example, mica particles coated with at least one metal oxide. In addition to mica, a phyllosilicate, silica gel and other SiO ₂ modifications are also suitable as carriers. A metal oxide frequently used for coating is, for example, titanium oxide, to which iron oxide may be added, if desired. The size and shape (eg spherical, ellipsoidal, flattened, even, uneven) of the pigment particles as well as the thickness of the oxide coating can influence the reflection properties. Other metal oxides, eg. B. bismuth oxychloride (BiOCl), and the oxides of, for example, titanium, in particular the TiO ₂ modifications anatase and rutile, aluminum, tantalum, niobium, zirconium and hafnium can be used. Also with magnesium fluoride (MgF ₂ ) and calcium fluoride (fluorspar, CaF ₂ ) effect pigments can be produced.

The effects can be controlled both by the particle size and by the particle size distribution of the pigment ensemble. Suitable particle size distributions range z. B. 2-50 microns, 5-25 microns, 5-40 μ m, 5-60 μm, 5-95 μm, 5-100 μm, 10-60 μm, 10-100 μm, 10-125 μm, 20-100 μm, 20-150 μm, and <15 μm. A broader particle size distribution z. B. 20-150 microns, produces glittering effects, while a narrower particle size distribution of <15 microns ensures a uniform silky appearance.

The Contain compositions of the invention Effect pigments, preferably in amounts of from 0.1 to 20.0% by weight, especially preferably from 0.5 to 10.0 wt .-% and particularly preferably from 1.0 to 5.0 wt .-%, each based on the total weight of the composition.

When deodorants are preferred are allantoin and bisabolol. These are preferably used in amounts of 0.0001 to 10.0 wt .-%.

When Fragrance or perfume oils can be individual Fragrance compounds, eg. B. the synthetic products of the type the esters, ethers, aldehydes, ketones, alcohols and hydrocarbons be used. Fragrance compounds of the ester type are z. Benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, Linalyl acetate, dimethylbenzylcarbinylacetate, phenylethylacetate, Linalyl benzoate, benzyl formate, ethyl methyl phenyl glycinate, allyl cyclohexyl propionate, Styrallyl propionate and Benzylsalicylate. Count to the Ethern for example, benzyl ethyl ether, to the aldehydes z. B. the linear Alkanals of 8 to 18 C atoms, citral, citronellal, citronellyloxyacetaldehyde, Cyclamehaldehyde, Hydroxycitronellal, Lilial and Bourgeonal, too the ketones z. The ionones, alpha-isomethyl-ionone and methyl-cedryl-ketone, to the alcohols anethol, citronellol, eugenol, geranion, linalol, Phenylethyl alcohol and terpineol belong to the hydrocarbons mainly the terpenes and balms. To be favoured Mixtures of different fragrances used together create an appealing scent.

perfume oils may also contain natural fragrance mixtures, as accessible from plant or animal sources are, for. Pine, citrus, jasmine, lily, rose, or ylang-ylang oil. Also essential oils of lower volatility, which are mostly used as aroma components, are suitable as Perfume oils, e.g. Sage oil, chamomile oil, Clove oil, lemon balm oil, mint oil, cinnamon leaf oil, Lime blossom oil, juniper berry oil, vetiver oil, Oliban oil, galbanum oil and ladanum oil.

When pearlescing component are preferably suitable fatty acid monoalkanolamides, Fatty acid dialkanolamides, monoesters or diesters of alkylene glycols, in particular ethylene glycol and / or propylene glycol or its oligomers, with higher fatty acids, such as. For example palmitic acid, Stearic acid and behenic acid, monoesters or polyesters of glycerol with carboxylic acids, fatty acids and their metal salts, ketosulfones or mixtures of said compounds. Particularly preferred are ethylene glycol distearates and / or polyethylene glycol distearates with an average of 3 glycol units.

Provided the compositions according to the invention pearlescing Compounds containing these are preferred in an amount of 0.1 to 15.0 wt .-% and particularly preferably in an amount of 1.0 to 10.0 wt .-% in the compositions of the invention contain.

When Acids or alkalis for pH adjustment are preferably Mineral acids, in particular HCl, inorganic bases, in particular NaOH or KOH, and organic acids, especially citric acid, used.

The The following examples and applications are intended to illustrate the invention in more detail but without restricting it. All percentages are by weight (% by weight).

Production examples, general working instructions:

at the preparation of the phosphoric acid esters of the formula (I) Phosphoric acid (85%), and fatty alcohol ethoxylate in one used specific molar ratio. This will be all Edukte in a stirring apparatus with heating mushroom, Auskreiser presented with cooler and vacuum connection. The mixture is heated to 100 ° C, evacuated three times to 100 mbar and then re-aerated with nitrogen. After a further 4 hours inertization (nitrogen introduction of 20 liters / hour) at 100 ° C, the approach under nitrogen is introduced heated to 230 ° C and esterified (water discharge). The Reaction times are 24 to 42 hours (from 230 ° C esterification temperature calculated), in particular 40 hours. The residual acid number is then <3 mg KOH / g. This corresponds to about 93 to 96% conversion (based on starting acid number). After completion of the reaction, the product is cooled to 80 ° C, poured into a dish and crushed the solidified melt.

Example 1:

Ester of 12.7 g of phosphoric acid and 701.3 g of ceteareth-50 (C _16/18 fatty alcohol + 50 mol of ethylene oxide) in a molar ratio of 1: 3, residual acid number: 0.8 mg KOH / g (97% conversion),
³¹ P-NMR: diester / triester = 13/87 mol%

Example 2:

Ester from 11.4 g phosphoric acid and 935.1 g ceteareth-80 (C _16/18 fatty alcohol + 80 mol ethylene oxide) in the molar ratio 1: 3, residual acid number: 0.8 mg KOH / g (96% conversion),
³¹ P-NMR: diester / triester = 15/85 mol%

Comparative Example 1

Ester of 17.3 g phosphoric acid and 666.0 g ceteareth-25 (C _16/18 fatty alcohol + 25 mol ethylene oxide) in the molar ratio 1: 3, residual acid number: 1.7 mg KOH / g (95% conversion),
³¹ P-NMR: diester / triester = 11/89 mol%

viscosity measurements in aqueous compositions

The viscosities of the organophosphate of Examples 1 and 2 and of Comparative Example 1 in comparison to the commercial products Crothix (PEG-150 pentaerythrityl tetrastearate), Genapol ^® DAT 100 (PEG-150 Polyglyceryl-2 Tristearate) and Rewopal ^® PEG 6000 DS (PEG-150 Distearate) was measured (each 6 wt .-% product in water). Viscosity was measured at 20 ° C with a Brookfield type RVT viscometer at 20 rpm immediately after preparation of the aqueous compositions ("Viscosity Immediate") and after 3 months storage at room temperature (RT). Table 1 Viscosities of aqueous compositions product Viscosity immediately [mPa · s] clarity Viscosity after 3 months storage at RT [mPa.s] example 1 29400 clear 23000 Example 2 19200 clear 16000 Comparative Example 1 58 clear 40 PEG-150 pentaerythrityl tetrastearate 6650 cloudy 990 PEG-150 polyglyceryl-2-tristearate 65 cloudy nb PEG-150 distearate 3900 cloudy nb

• RT: room temperature; n. b. not determined

The results in Table 1 show that Examples 1 and 2 according to the invention form clear, high-viscosity gels in water which retain their viscosity even after storage for 3 months at room temperature (RT). Phosphoric acid esters with a lower degree of ethoxylation (derived from C _16/15 fatty alcohol + 25 moles of ethylene oxide) show only a very slight thickening power.

viscosity measurements in aqueous-surfactant compositions

The viscosities of the organophosphate of Examples 1 and 2 and of Comparative Example 1 in comparison to the commercial products Crothix (PEG-150 pentaerythrityl tetrastearate), Genapol ^® DAT 100 (PEG-150 Polyglyceryl-2 Tristearate) and Rewopal ^® PEG 6000 DS (PEG-150 Distearate) was measured (each 1% by weight of product in an aqueous solution of sodium lauryl ether sulfate: cocoamidopropyl betaine in the ratio 8: 2 with a total surfactant content of 15% by weight in water, pH 4-4.4). The viscosity was measured at 20 ° C with a Brookfield type RVT viscometer at 20 rpm, immediately after preparation of the aqueous-surfactant compositions ("Viscosity immediate") and after 3 months storage at 50 ° C. Table 2 Viscosities of aqueous-surfactant compositions product Viscosity immediately [mPa · s] Viscosity after 3 months storage at 50 ° C [mPa · s] example 1 61000 63000 Example 2 24700 30000 Comparative Example 1 785 400 PEG-150 pentaerythrityl tetrastearate 20000 80 PEG-150 polyglyceryl-2-tristearate 23100 110 PEG-150 distearate 2750 45

The Results of Table 2 show that the invention Examples 1 and 2 highly viscous gels in surfactant-containing formulations form, which also after 3 months of storage at 50 ° C their Maintain viscosity.

The following formulation examples show the use of the phosphoric acid esters of the formula (I) in aqueous and surfactant formulations according to the invention. Formulation Example 1 (Facial Cleansing Foam) A stearic acid 1.60% myristic 1.80% lauric acid 0.70% Tegin M 00:50% Glyceryl stearate palmitic 0.70% B water ad 100.00% C potassium hydroxide 0.70% Phosphoric acid ester Example 1 1:00% production: I A melt at 80 ° C. II Dissolve C in B with stirring and at 60 ° C, then add to I. III Cool with stirring. Formulation Example 2 (Cream Rinse) A Genamin ^® CTAC (Clariant) 6:00 am% Cetrimonium chlorides Hostacerin ^® DGL (Clariant) 1:50% PEG-10 diglyceryl-2 laurate Cetylstearyl alcohol 1.70 paraffin oil 1:00% B water ad 100.00% C Phosphoric acid ester Example 2 1:00% D Perfume 00:30% panthenol 00:30% preservative qs dye qs production: I A melt at 75 ° C. II Dissolve C in B with stirring at 60 ° C. III II to I with stirring. Stir cold. IV At 40 ° C, add the components of D. V Adjust the pH to 4. Formulation Example 3 (Light Leave on for Hair Tips) A SilCare ^® Silicone 41M15 (Clariant) 00:30% Caprylyl Methicone B Genapol ^® LA 070 (Clariant) 8.00% Laureth-7 C water ad 100% D Phosphoric acid ester Example 2 2:00% e Biobranil 00:50% Soybean (Glycine Soy) Oil and Wheat (Triticum Vulgare) Bran Lipids glycerin 2:00% panthenol 00:50% F SilCare® ^® Silicone SEA (Clariant) 00:50% Trideceth-9 PG Amodimethicone and T rideceth-12 Genamin ^® CTAC (Clariant) 2:00% Cetrimonium chlorides Nipaguard ^® DMDMH (Clariant) of 0.20% DMDMH Hydantoin production: I Solubilize A in B. II Dissolve D in C with stirring at 60 ° C. III Add E to II and stir until the solution is clear, then add to I. IV Give F to III. Formulation Example 4 (hydrogen peroxide gel) A Phosphoric acid ester Example 1 5.00% Genapol ^® T 250 (Clariant) 2:00% Ceteareth-25 B water ad 100.00% C phosphoric acid 00:04% sodium 1:00% D Hydrogen peroxide 30% 18.00% production: I Dissolve A in B while stirring and heating to 50 ° C. II Add at 25 ° CC. III Add at room temperature. Formulation Example 5 (Deodorant Gel) A Octopirox® ^® (Clariant) ≤ 0.10% Piroctone Olamine B Emulsogen® ^® HCP 049 (Clariant) 10.00% PEG-40 Hydrogenated Castor Oil and Propylene glycol Perfume of 0.20% C water ad 100.00% D Phosphoric acid ester Example 2 3:00% e citric acid qs production: I Release A in B. II Dissolve D in C with stirring and gentle heating, then add II to I. III If necessary, adjust the pH to 6.0 with E. Formulation Example 6 (Make-Up Remover) A Velsan® ^® P8-3 (Clariant) 5.00% Isopropyl C _12-15 Pareth-9 Carboxylates B Hostapon® ^® CGN (Clariant) 2:00% Sodium Cocoyl Glutamate Genagen ^® CAB (Clariant) 3:00% Cocamidopropyl betaines allantoin (Clariant) 00:30% Aristoflex® ^® PEA (Clariant) 1:00% Polypropylene terephthalate 1.6 hexanediol 2:00% 1.2 Propanediol 2:00% Polyglycol 400 (Clariant) 2:00% PEG-8 panthenol 00:50% Lutrol F 127 3:00% Poloxamer 407 preservative qs C Phosphoric acid ester Example 1 1:00% D water ad 100.00% e Genapol ^® LA 070 (Clariant) 2:00% Laureth-7 production: I Gradually add the components from B to A and stir until a clear solution is obtained. II Dissolve C in D with stirring and gentle heating, add II to I. III Stir in I Formulation Example 7 (Whitening Gel) A water ad 100.00% arginine 10.01% Phosphoric acid ester Example 1 4:00% B dipropylene 8.00% Genapol ^® C 100 (Clariant) 0.60% Coceth-10 Sodium citrate * 2H ₂ O 0.09% to Citric acid 10.0% ≤ 0.10% Nipagin ^® M (Clariant) of 0.20% Methylparaben ascorbic acid-2-glucoside 2:00% production: I Mix the components of A and dissolve with stirring and gentle heating. II Give the components from B to I and solve. If necessary, heat the formulation slightly. Formulation Example 8 (Facial Toner) A glycerin 8.00% Polyglycol 400 (Clariant) 5.00% PEG-8 panthenol 00:50% Perfume of 0.20% alcohol 8.00% preservative qs allantoin (Clariant) ≤ 0.10% Niacinamide ≤ 0.10% Extrapon witch hazel 1:00% Water, Witch Hazel Distillate, SD Alcohol 39-C, Butylene Glycols B water ad 100% C Phophorsäureester Example 2 2:00% production: I Dissolve C in B with stirring and gentle heating. II Add the components from A to I and stir until the formulation is homogeneous. Formulation Example 9 (Hair Shampoo) A Genapol ^® LRO liquid (Clariant) 30.00% Sodium Laureth Sulfate Hostapon® ^® CGN (Clariant) 5.00% Sodium Cocoyl Glutamate Perfume 00:30% B water ad 100.00% C Phosphoric acid ester Example 2 1:50% preservative qs dye qs Genagen ^® CAB (Clariant) 8.00% Cocamidopropyl betaines production: I Dissolve C in B with stirring and heating to 50 ° C. II Gradually stir in the components of A in I. III If necessary, adjust the pH. Formulation Example 10 (bubble bath) A Genapol ^® LRO liquid (Clariant) 60.00% Sodium Laureth Sulfate (30% by weight) Active content) B Medialan ^® LD (Clariant) 8.00% Sodium lauroyl sarcosinate Perfume 1:50% Velsan® ^® CG 070 (Clariant) 5:00 PEG-7 glyceryl cocoate C Phosphoric acid ester Example 2 1:00% D water ad 100% e dye qs preservative qs Genagen ^® CAB (Clariant) 6:00 am% Cocamidopropyl betaines production: I Gradually stir in the components of B in A. II Dissolve C in D with stirring and heating to 50 ° C. III I give to II. VI Stir in III. V If necessary, adjust the pH. Formulation Example 11 (O / W Skinmilk) A Hostacerin ^® DGI (Clariant) 2:00% Polyglyceryl-2 sesquiisostearates isopropyl palmitate 4:00% octyldodecanol 4:00% Nipaguard ^® PDU (Clariant) qs Propylene glycol (and) diazolidinyl urea (and) methylparaben (and) Propylparaben B Aristoflex® ^® AVC (Clariant) 01.20% Ammonium acryloyldimethyltaurate / VP copolymer C Hostapon® ^® CGN (Clariant) 0.60% Sodium Cocoyl Glutamate water ad 100% D Phosphoric acid ester Example 1 1:00% e Perfume 0.40% production: I Dissolve D in C with stirring and heating to 50 ° C. II Add B to A, then add I and stir well. III E to II. IV Finally, homogenize the formulation. Formulation Example 12 (antiperspirant roll-on) A Phosphoric acid ester Example 2 1:50% B water ad 100.00% C Locron ^® L (Clariant) 8:00 pm% Aluminum Chlorohydrate D Genapol ^® T 250 (Clariant) 5.00% Ceteareth-25 Butylene glycol 3:00% Cetiol OE 1:00% Dicaprylyl ether Glyceryl isostearate 2:00% e SilCare® ^® Silicone SEA (Clariant) 00:50% Trideceth-9 PG Amodimethicone and Trideceth-12 production: I Dissolve A in B with stirring and heating to 60 ° C. II Give C to I. 111 D melt at 50 ° C and add II, stirring, until a clear solution originated. IV Add at 30 ° CE.

Formulation Example 12 showed a marked reduction in white residue on clothing after application of skin roll-on to the same formulation but without the phosphoric acid ester of Example 2. Formulation Example 13 (Vitamin C Gel) A Phosphoric acid ester Example 2 1:00% Genapol ^® T 250 (Clariant) 2:00% Ceteareth-25 B water ad 100.00% C ascorbic acid 3:00% D Aristoflex AVC (Clariant) 0.80% Ammonium acryloyldimethyltaurate / VP copolymer production: I Dissolve A in B with stirring at 50 ° C. II Stir C in I at room temperature. III Add D and stir until a homogeneous gel has formed. Formulation Example 14 (Shower Bath) A Phosphoric acid ester Example 2 (Clariant) 3:00% Aristoflex® ^® PEA (Clariant) 2:00% Polypropylene terephthalate B water ad 100% C Genapol ^® LRO liquid (Clariant) 30.00% Sodium Laureth Sulfate Genapol ^® LA 030 (Clariant) 1:50% Laureth-3 Hostapon® ^® CLG (Clariant) 5.00% Sodium Lauroyl Glutamate Genagen ^® KB (Clariant) 6:00 am% Coco betaine Perfume 00:30% dye qs preservative qs production: I Dissolve A in B at 50 ° C. II Stir the components of C into I successively. III If necessary adjust the pH value. Formulation Example 15 (Facial Anti-Aging Cream Gel) A Phosphoric acid ester Example 1 (Clariant) 1:00% B water ad 100.00% C paraffin oil 5.00% SilCare ^® Silicone 31M50 (Clariant) 3:00% Caprylyl trimethicone D Aristoflex® ^® AVC (Clariant) 1.80% Ammonium acryloyldimethyltaurate / VP copolymer e Glycolic acid 30% * 6:00 am% Phenonip ^® (Clariant) 00:50% Phenoxyethanol (and) Methylparaben (and) Ethylparaben (and) Butylparaben (and) Propylparaben (and) Isobutylparaben F Genapol ^® LA 070 (Clariant) 2:00% Laureth-7

• * neutralized with NaOH to pH 4.

production: I Dissolve A in B with stirring at 50 ° C. II Stir D into C. III Stir into II and stir until a homogeneous gel has formed. IV Add E in III. V Stir in F and stir until the cream gel is homogeneous. Formulation example 16 (O / W self-tanning cream) A Hostaphat ^® CC 100 (Clariant) 1.0% Cetyl phosphates Glyceryl stearate 0.5% Cetearyl alcohol 0.5% paraffin oil 8.0 isopropyl palmitate 7.0 SilCare ^® Silicone 41M15 (Clariant) 1.0% Caprylyl Methicone B Aristoflex® ^® AVC (Clariant) 01.02% Ammonium acryloyldimethyltaurate / VP copolymer C water ad 100% D Phosphoric acid ester Example 1 (Clariant) 1.0% e Hostapon® ^® CLG (Clariant) 0.5% Sodium Lauroyl Glutamate glycerin 5.0% F Tocopheryl acetate 1.0% Fragrance 0.2 Preservative qs G Dihydroxyacetone 5.0% H water 8.0% Sodium hydroxide (10% in water) qs production: I A melt at 80 ° C. II Stir B into A. III Dissolve D in C at 50 ° C, then add E. IV Stir in III in II. V Add room temperature at room temperature. VI Release G in H and stir in V. VII If necessary adjust the pH value with 1 to 4-5. Formulation Example 17 (O / W Sunscreen Milk) A Hostaphat ^® CK 100 (Clariant) 2:00% Potassium Cetyl Phosphate SilCare ^® Silicone 41M15 (Clariant) 1:00% Caprylyl Methicone stearic acid 00:50% Cetyl alcohol 00:50% Cutina ^® GMS 1:00% Glyceryl stearate Cetiol ^® SN 4:00% Cetearyl isononanoate Velsan® ^® CCT (Clariant) 4:00% Caprylic / Capric Triglycerides ^Neo® Heliopan BB 1:50% Benzophenones - 3 Eusolex ^® 6300 4:00% 4-methylbenzylidene camphor B Aristoflex® ^® AVC (Clariant) 0.40% Ammonium acryloyldimethyltaurate / VP copolymer C water ad 100% D Phosphoric acid ester Example 2 (Clariant) 1:00% e glycerin 3:00% Eusolex® 232 2:00% Phenylbenzimidazole sulfonic acid Tris (hydroxymethyl) aminomethane 10.01% tromethamine F Tocopheryl acetate 00:50% Phenonip ^® (Clariant) 00:50% Phenoxyethanol (and) Methylparaben (and) Butylparaben (and) Ethylparaben (and) propylparaben Fragrance 0.40% production: I A melt at 80 ° C, then add B. II Dissolve D in C at 60 ° C. III Stir E into II. IV Solve III in I. V Add at 35 ° C in IV. Formulation Example 18 (Facial Anti-Aging Gel) A Genapol ^® T 250 (Clariant) 1:00% Ceteareth-25 Phosphoric acid ester Example 2 (Clariant) 1:00% B water ad 100% C Aristoflex® ^® AVC (Clariant) 2:00% Ammonium acryloyldimethyltaurate / VP copolymer D Glycolic acid 30% * 6:00 am% Phenonip ^® (Clariant) 00:50% Phenoxyethanol (and) Methylparaben (and) Ethylparaben (and) Butylparaben (and) Propylparaben (and) Isobutylparaben

• * neutralized with NaOH to pH 4.

production: I Dissolve A in B with stirring at 50 ° C. II Add C and stir until a homogeneous gel has formed. III Add D and stir until the gel is homogeneous again. Formulation Example 19 (Hair Shampoo) A Genapol ^® LRO liquid (Clariant) 30.00% Sodium Laureth Sulfate Hostapon® ^® CGN (Clariant) 5.00% Sodium Cocoyl Glutamate Perfume 00:30% B water ad 100.00% C Phosphoric acid ester Example 2 1:50% benzoic acid 00:50% dye qs Genagen ^® CAB (Clariant) 8.00% Cocamidopropyl betaines production: I Dissolve C in B with stirring and heating to 50 ° C. II Gradually stir in the components of A in I. III Adjust the pH to 4.9. Formulation Example 20 (bubble bath) A Genapol ^® LRO liquid (Clariant) 60.00% Sodium Laureth Sulfate (30% by weight) Active content) B Medialan ^® LD (Clariant) 8.00% Sodium lauroyl sarcosinate Perfume 1:50% Velsan® ^® CG 070 (Clariant) 5.00% PEG-7 glyceryl cocoate C Phosphoric acid ester Example 2 1:00% D water ad 100% e dye qs sorbic acid 0.60% Genagen ^® CAB (Clariant) 6:00 am% Cocamidopropyl betaines production: I Gradually stir in the components of B in A. II Dissolve C in D with stirring and heating to 50 ° C. III I give to II. VI Stir in III. V Adjust the pH to 4.8. Formulation example 21 (shower bath) A Phosphoric acid ester Example 2 (Clariant) 3:00% Aristoflex® ^® PEA (Clariant) 2:00% Polypropylene terephthalate B water ad 100% C Genapol ^® LRO liquid (Clariant) 30.00% Sodium Laureth Sulfate Genapol ^® LA 030 (Clariant) 1:50% Laureth-3 Hostapon® ^® CLG (Clariant) 5.00% Sodium Lauroyl Glutamate Genagen ^® KB (Clariant) 6:00 am% Coco betaine Perfume 00:30% dye qs sodium salicylate 00:50% production: I Dissolve A in B at 50 ° C. II Stir the components of C into I successively. III Adjust the pH to 4.5.

QUOTES INCLUDE IN THE DESCRIPTION

This list The documents listed by the applicant have been automated generated and is solely for better information recorded by the reader. The list is not part of the German Patent or utility model application. The DPMA takes over no liability for any errors or omissions.

Cited patent literature

• - DE 102004047092 [0008]
• US 6448297 [0008]
• - DE 102004046356 [0008]
• - JP 09268193 [0009]
• US 5129462 [0010, 0012]
• - EP 1518900 [0011, 0012]
• - EP 1344518 [0011, 0012]

Claims (21)

Composition comprising A) one or more phosphoric esters of the formula (I)

wherein R ₁ , R ₂ and R _{3 may be the} same or different and is a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22 and particularly preferably 12 to 18 carbon atoms, a linear or branched, one or more times unsaturated alkenyl group having 6 to 30, preferably 8 to 22 and particularly preferably 12 to 18 carbon atoms, or an aryl group, in particular a phenyl group containing 1 to 3 branched alkyl groups, each independently 3 to 18 and preferably 4 to 12 carbon atoms , may be substituted, the individual groups (OA ₁ ) _x , (A ₂ O) _y and (A ₃ O) _{z are} each independently selected from units selected from CH ₂ CH ₂ O, C ₃ H ₆ O and C ₄ H ₈ O and wherein the units CH ₂ CH ₂ O, C ₃ H ₆ O and C ₄ H ₈ O within the individual groups (OA ₁ ) _x , (A ₂ O) _y and (A ₃ O) _z block-like or can be arranged statistically distributed, and x, y and z each independently each other is a number from 30 to 150, preferably from 40 to 120 and particularly preferably from 51 to 100, and B) water in an amount of> 50.0 wt .-%, preferably in an amount> 70.0 wt. -%, and more preferably in an amount of 75.0 to 95.0 wt .-%, based on the finished composition. A composition according to claim 1, characterized in that R ₁ , R ₂ and R ₃ in the phosphoric acid esters of formula (I) may be the same or different and represent a linear or branched, saturated alkyl group of 6 to 30, preferably 8 to 22 and especially preferably 12 to 18 carbon atoms, or a linear or branched, mono- or polyunsaturated alkenyl group having 6 to 30, preferably 8 to 22 and particularly preferably 12 to 18 carbon atoms. Composition according to Claim 1 or 2, characterized in that OA ₁ , OA ₂ and OA ₃ in the phosphoric acid esters of the formula (I) denote CH ₂ CH ₂ O. Composition according to one or more of Claims 1 to 3, characterized in that R ₁ - (OA ₁ ) _x , R ₂ - (OA ₂ ) _y and R ₃ - (OA ₃ ) _{z are derived} in the phosphoric acid esters of the formula (I) are fatty alcohol ethoxylates selected from C _16/18 fatty alcohol ethoxylates having 30 to 150 ethylene oxide units, preferably with 40 to 120 ethylene oxide units, more preferably from C _16/18 fatty alcohol ethoxylate with 50 ethylene oxide units or C _16/18 fatty alcohol ethoxylate with 80 ethylene oxide units. Composition according to one or more of Claims 1 to 4, characterized in that, in addition to the one or more phosphoric esters of the formula (I), it comprises one or more phosphoric esters of the formula (II)

wherein R _{1 is} a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22 and especially preferably 12 to 18 carbon atoms, for a linear or branched, mono- or polyunsaturated alkenyl group having 6 to 30, preferably 8 to 22 and particularly preferably 12 to 18 carbon atoms, or for an aryl group, in particular a phenyl group, which branched with 1 to 3 R _{4 is} H, Li ⁺ , Na ⁺ , K ⁺ , Mg ⁺⁺ , Ca ⁺⁺ , Al ⁺⁺⁺ , R _{4 is} alkyl, each of which may independently contain 3 to 18 and preferably 4 to 12 carbon atoms, NH ₄ ⁺ or quaternary ammonium ions [HNR ^a R ^b R ^c ] ⁺ , wherein R ^a , R ^b and R ^{c are} independently hydrogen, a linear or branched alkyl group having 1 to 22 carbon atoms, a linear or branched, monounsaturated or polyunsaturated Alkenyl group having 2 to 22 carbon atoms, a linear mono-hydroxyalkyl group having 2 to 10 carbon atoms, preferably a mono-hydroxyethyl or mono-hydroxypropyl group, or a linear or branched di-hydroxyalkyl group mi t is 3 to 10 carbon atoms, R _{5 has} the meaning of R ₁ or R ₄ , the individual groups (OA ₁ ) and (A ₂ O) _w each independently of one another from units selected from CH ₂ CH ₂ O, C ₃ H ₆ O and C ₄ H ₈ O exist and wherein the units CH ₂ CH ₂ O, C ₃ H ₆ O and C ₄ H ₈ O within the individual groups (OA ₁ ) _x and (A ₂ O) _w block-wise or randomly distributed x is a number from 30 to 150, preferably from 40 to 120 and particularly preferably from 51 to 100, and w is 0 or from 30 to 150, preferably from 40 to 120 and more preferably from 51 to 100, provided that the amount of phosphoric acid triesters according to formula (I) greater than 80.0 wt .-%, preferably from 85.0 to 99.0 wt .-% and particularly preferably from 88.0 to 95.0 wt .-%, based on the total weight of the phosphoric acid esters of formula (I) and formula (II), and the degree of neutralization of the non-esterified Phosphorvalences (P-OH) in d Phosphoric acid esters of formula (II) can be between 0 and 100%. Composition according to Claim 5, characterized in that it contains one or more compounds of the formula (II) in which R ^{5 has} the meaning of R ¹ , and w denotes a number from 30 to 150, preferably from 40 to 120 and more preferably from 51 to 100 stands. Composition according to one or more of the claims 1 to 6, characterized in that it contains water in an amount> 90.0 wt .-% and preferred in an amount of 90.1 to 95.0 wt .-%, based on the finished Composition containing. Composition according to one or more of the claims 1 to 7, characterized in that they one or more Phosphoric acid esters of the formula (I) in an amount of 0.1 to 10.0 wt .-%, preferably from 0.5 to 8.0 wt .-% and especially preferably from 1.0 to 6.0% by weight, based on the finished composition, contains. Composition according to one or more of the claims 1 to 8, characterized in that they contain one or more surfactants contains. Composition according to Claim 9, characterized that they contain the one or more phosphoric acid esters of the formula (I) in an amount of 0.1 to 5.0% by weight, preferably from 0.2 to 4.0% by weight, and more preferably from 0.5 to 3.0% by weight, based on the finished composition. Composition according to one or more of the claims 1 to 10, characterized in that they are a cosmetic, pharmaceutical or dermatological composition. Composition according to one or more of the claims 1 to 11, characterized in that they are in the form of an aqueous, aqueous-alcoholic or aqueous-surfactant Composition, an emulsion, suspension, dispersion or a Sprays is present. Composition according to one or more of the claims 1 to 12, characterized in that they have a pH of 2 to 10, preferably from 2 to 6, more preferably from 2.5 to 5 and more preferably from 3 to 4.5. Composition according to one or more of the claims 1 to 13, characterized in that they have a pH of 2.5 to 5 and, based on the total composition of 0.05 to 3.0 wt .-%, preferably from 0.05 to 2.0 wt .-% and especially preferably from 0.1 to 1.0% by weight of one or more organic Acids with antimicrobial activity, preferably carboxylic acids with antimicrobial action. Composition according to one or more of the claims 1 to 14, characterized in that they contain one or more electrolytes contains. Composition according to Claim 15, characterized that the amount of one or more electrolytes, based to the finished composition, from 0.1 to 20.0 wt .-%, preferably from 0.2 to 10.0 wt%, and more preferably from 0.5 to 5.0 Wt .-%, is. Composition according to one or more of the claims 1 to 16, characterized in that they hydrogen peroxide or Contains hydrogen peroxide-releasing substances, and preferably in the form of a gel or cream. Composition according to one or more of the claims 1 to 17, characterized in that they are a deodorant or Antiperspirant formulation is, in particular a deodorant or Antiperspirant formulation containing one or more aluminum salts, preferably aluminum chlorohydrate or aluminum-zirconium complex salts. Use of one or more phosphoric acid esters of the formula (I) in a composition according to claim 18 for reduction the formation of white residues on the Clothing after application of the deodorant or antiperspirant formulation on the skin. Use of one or more phosphoric acid esters of the formula (I) in a composition of one or more of claims 1 to 18 as thickener, bodying agent, Emulsifier, sensor additive, solubilizer, dispersant, lubricant, Adhesive or stabilizer. Use of one or more phosphoric acid esters of the formula (I) in a composition of one or more of claims 1 to 18 as a thickener.